{"altmetric_id": 88564054, "counts": {"readers": {"citeulike": "0", "mendeley": "249", "connotea": "0"}, "total": {"posts_count": 773}, "twitter": {"unique_users_count": 599, "posts_count": 648}, "news": {"unique_users_count": 91, "unique_users": ["stat_news", "seeking_alpha", "daily_mail", "bet365", "readsector", "the_amed_post", "msn", "pressfrom", "business_wire", "digital_journal", "dmn_newswire", "stockwatch", "finanz_nachrichten", "ariva", "morning_star", "the_street", "benzinga", "globenewswire", "crwe_world", "finanzen", "tcmnet_com", "finanzen_ch", "biz_wire_express", "yahoo_news", "kulr_8", "pm_360", "spoke", "cnbc", "daily_journal_tupelo", "post_register", "the_daily_times", "einpresswire", "jotup", "shares_magazine", "the_cw_wbcb", "biocentury", "biospace", "nasdaq", "biotech_gate", "gurufocus", "pharmazeutische_zeitung", "pharmiweb", "fierce_biotech", "yahoo_finance_usa", "bgr", "medpage_today", "google_news", "the_verge", "replicario", "true_viral_news", "the_medical_news", "trialsite_news", "inverse", "express_informer", "cbc", "international_business_times", "polit", "i3investor", "new_york_times", "salon", "rolling_stone", "yahoo", "nbc4", "nbc_miami", "newsmax_com", "the_conversation", "red_accion", "yahoo_finance_canada", "sabado_portugal", "detroit_free_press", "washington_post", "newsbeezer", "the_scientist_magazine", "aftenposten", "apa", "aljazeera", "foreign_affairs_new_zealand", "big_news_network", "your_life_choices", "medicalxpress", "globalresearcg", "orf_at", "the_standard", "heute", "chicago_tribune", "baltimore_sun", "lancaster_online", "fox_news_26", "the_bakersfield_californian", "herald_mail_media", "union_bulletin"], "posts_count": 114}, "blogs": {"unique_users_count": 7, "unique_users": [59550, 80146, 80204, 79518, 51890, 369, 79832], "posts_count": 7}, "wikipedia": {"unique_users_count": 2, "unique_users": ["en:58045046", "sv:8510382"], "posts_count": 2}, "video": {"unique_users_count": 2, "unique_users": ["Aaditya D Singh", "SciShow"], "posts_count": 2}}, "citation": {"altmetric_jid": "medrxiv", "authors": ["Walsh, Edward E.", "Frenck, Robert", "Falsey, Ann R.", "Kitchin, Nicholas", "Absalon, Judith", "Gurtman, Alejandra", "Lockhart, Stephen", "Neuzil, Kathleen", "Mulligan, Mark J.", "Bailey, Ruth", "Swanson, Kena A.", "Li, Ping", "Koury, Kenneth", "Kalina, Warren", "Cooper, David", "Fontes-Garfias, Camila", "Shi, Pei-Yong", "T\u00fcreci, \u00d6zlem", "Tompkins, Kristin R.", "Lyke, Kirsten E.", "Raabe, Vanessa", "Dormitzer, Philip R.", "Jansen, Kathrin U.", "\u015eahin, U\u011fur", "Gruber, William C."], "doi": "10.1101/2020.08.17.20176651", "first_seen_on": "2020-08-20T14:24:14+00:00", "issns": [], "last_mentioned_on": 1619715470, "links": ["https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v1", "https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v1.full.pdf", "https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v2", "https://doi.org/10.1101/2020.08.17.20176651", "https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v2.full.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444302/", "http://medrxiv.org/content/10.1101/2020.08.17.20176651v2", "https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v2?fbclid=IwAR2GkOWh0XKljE5iHsUTrM54whJ8mV_VbbLsTDUY31xD8vEjdf06OHnh0iE", "http://dx.doi.org/10.1101/2020.08.17.20176651", "https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v1?versioned=true", "https://pubmed.ncbi.nlm.nih.gov/32839784/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444302/?report=printable", "https://dx.doi.org/10.1101/2020.08.17.20176651", "https://www.medrxiv.org/content/medrxiv/early/2020/08/20/2020.08.17.20176651.full.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444302", "https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v2#disqus_thread", "https://www.medrxiv.org/content/10.1101/2020.08.17.20176651v2.full"], "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/08/20/2020.08.17.20176651.full.pdf", "pmid": "32839784", "publisher": "Cold Spring Harbor Laboratory", "title": "RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/99cdbabd-744b-30d0-a04c-37d4255b62fb/"}, "altmetric_score": {"score": 1155.704, "score_history": {"1y": 1155.704, "6m": 176.28, "3m": 15.2, "1m": 1.85, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 1155.704}, "context_for_score": {"all": {"total_number_of_other_articles": 17759439, "mean": 9.45271436671, "rank": 6254, "this_scored_higher_than_pct": 99, "this_scored_higher_than": 17755180, "rank_type": "exact", "sample_size": 17759439, "percentile": 99}, "similar_age_3m": {"total_number_of_other_articles": 305425, "mean": 18.002496678398, "rank": 456, "this_scored_higher_than_pct": 99, "this_scored_higher_than": 304966, "rank_type": "exact", "sample_size": 305425, "percentile": 99}, "this_journal": {"total_number_of_other_articles": 20281, "mean": 54.693235836497, "rank": 187, "this_scored_higher_than_pct": 99, "this_scored_higher_than": 20095, "rank_type": "exact", "sample_size": 20281, "percentile": 99}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 877, "mean": 177.64001140251, "rank": 31, "this_scored_higher_than_pct": 96, "this_scored_higher_than": 847, "rank_type": "exact", "sample_size": 877, "percentile": 96}}}, "demographics": {"poster_types": {"member_of_the_public": 510, "researcher": 65, "practitioner": 17, "science_communicator": 7}, "users": {"twitter": {"cohorts": {"Members of the public": 510, "Scientists": 65, "Science communicators (journalists, bloggers, editors)": 7, "Practitioners (doctors, other healthcare professionals)": 17}}, "mendeley": {"by_status": {"Student  > Postgraduate": 12, "Professor > Associate Professor": 5, "Researcher": 27, "Student  > Master": 25, "Student  > Ph. D. Student": 22, "Professor": 2, "Student  > Bachelor": 48, "Student  > Doctoral Student": 8, "Lecturer": 6, "Other": 15, "Librarian": 3, "Lecturer > Senior Lecturer": 2, "Unspecified": 2}, "by_discipline": {"Medicine and Dentistry": 48, "Social Sciences": 4, "Physics and Astronomy": 1, "Pharmacology, Toxicology and Pharmaceutical Science": 9, "Environmental Science": 3, "Unspecified": 2, "Chemical Engineering": 4, "Engineering": 3, "Chemistry": 8, "Neuroscience": 1, "Immunology and Microbiology": 20, "Computer Science": 3, "Agricultural and Biological Sciences": 18, "Nursing and Health Professions": 11, "Business, Management and Accounting": 3, "Biochemistry, Genetics and Molecular Biology": 35}}}, "geo": {"twitter": {"US": 69, "GB": 35, "FR": 2, "CA": 6, "SE": 3, "DE": 7, "TR": 75, "JP": 11, "AR": 5, "FI": 4, "TH": 1, "ES": 8, "CO": 1, "BR": 22, "AU": 4, "NL": 4, "PH": 2, "IN": 1, "SA": 2, "ID": 1, "PT": 4, "KM": 1, "AT": 2, "CH": 1, "NP": 1, "IT": 1, "CR": 1, "IE": 1, "MX": 1, "RO": 2, "PL": 1, "GE": 1, "MM": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "921400462838042624"}, "tweet_id": "1296442005778833411"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "33379661"}, "tweet_id": "1296448049766637575"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "43475268"}, "tweet_id": "1296455435558563840"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4859660471"}, "tweet_id": "1296455933430816769"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "19717430"}, "tweet_id": "1296455967417212928"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3142088601"}, "tweet_id": "1296456277204381698"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "849093025884237825"}, "tweet_id": "1296456714955489294"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1226199755694526472"}, "tweet_id": "1296457269169868804"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "536844934"}, "tweet_id": "1296458074446798849"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "427877977"}, "tweet_id": "1296459358025519105"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "632341632"}, "tweet_id": "1296460028971540482"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "28358443"}, "tweet_id": "1296460261788995584"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4859660471"}, "tweet_id": "1296460510079127555"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2571192054"}, "tweet_id": "1296460652240941058"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "427877977"}, "tweet_id": "1296460705303007234"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "845790620"}, "tweet_id": "1296460712743665665"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "373113388"}, "tweet_id": "1296460862400671748"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3126879118"}, "tweet_id": "1296460936442777600"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "733717446"}, "tweet_id": "1296461068211032064"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1633631874"}, "tweet_id": "1296461193746567171"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "635833627"}, "tweet_id": "1296461212729868290"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1260941107396894724"}, "tweet_id": "1296461536798617601"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "18021517"}, "tweet_id": "1296461764230557697"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "203643089"}, "tweet_id": "1296461857360838660"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1148766794"}, "tweet_id": "1296462142863020035"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "97467754"}, "tweet_id": "1296462582560231425"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "936668524877053952"}, "tweet_id": "1296463351120363521"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1279729933854490624"}, "tweet_id": "1296463595992227843"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "284918939"}, "tweet_id": "1296463987501076480"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "972552242"}, "tweet_id": "1296465833691090944"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1035738119956582400"}, "tweet_id": "1296467674655006720"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1288096460555386881"}, "tweet_id": "1296467996031029249"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2444409082"}, "tweet_id": "1296469900031078400"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "93142657"}, "tweet_id": "1296472236535230469"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "217726623"}, "tweet_id": "1296474945787232256"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "367403199"}, "tweet_id": "1296476947460087809"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1254342226366345217"}, "tweet_id": "1296476970037981185"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "517830342"}, "tweet_id": "1296481249989742594"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1589687850"}, "tweet_id": "1296483612594974720"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3295314779"}, "tweet_id": "1296487393734930433"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "633174310"}, "tweet_id": "1296487903850356738"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "28657430"}, "tweet_id": "1296489187231899649"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "360811827"}, "tweet_id": "1296501090649878533"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3166329193"}, "tweet_id": "1296504826726166529"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "338021789"}, "tweet_id": "1296505881312530433"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "38080472"}, "tweet_id": "1296506479353233412"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4238393893"}, "tweet_id": "1296506626921439239"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2180961493"}, "tweet_id": "1296507653666025473"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2964739114"}, "tweet_id": "1296509626452672518"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "834201804409692160"}, "tweet_id": "1296510594338574336"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "409194010"}, "tweet_id": "1296514467279364102"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "238495402"}, "tweet_id": "1296527403318157318"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "54998040"}, "tweet_id": "1296529006628675584"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1120464229784596483"}, "tweet_id": "1296529343246749697"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1053365439252836358"}, "tweet_id": "1296530791695097856"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "71331017"}, "tweet_id": "1296533743574884353"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "44412258"}, "tweet_id": "1296538697014431744"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "93490528"}, "tweet_id": "1296544853493452800"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "883458327211950081"}, "tweet_id": "1296556038129192960"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1247376635004936192"}, "tweet_id": "1296562035740876803"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3268963694"}, "tweet_id": "1296562182591672320"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "235776953"}, "tweet_id": "1296576652529598464"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2853619592"}, "tweet_id": "1296577002464374784"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "200434844"}, "tweet_id": "1296578835895353344"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4602250512"}, "tweet_id": "1296579090841911296"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "278446404"}, "tweet_id": "1296579654958977025"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "883458327211950081"}, "tweet_id": "1296580790604554240"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "249137662"}, "tweet_id": "1296582934942679040"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "303339927"}, "tweet_id": "1296586042296827906"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3543001941"}, "tweet_id": "1296603084215529472"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "23257566"}, "tweet_id": "1296611897664507904"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "51932290"}, "tweet_id": "1296632975367577607"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3242146196"}, "tweet_id": "1296633378519711744"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3092412299"}, "tweet_id": "1296644319923900416"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2225827864"}, "tweet_id": "1296646538287099906"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "291280258"}, "tweet_id": "1296650287508156417"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "795630211"}, "tweet_id": "1296659034058170368"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "737916752"}, "tweet_id": "1296662822525505536"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "41545870"}, "tweet_id": "1296677585389154307"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "42292798"}, "tweet_id": "1296685928040210434"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1007016660254056448"}, "tweet_id": "1296686828091781120"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "773306592938819584"}, "tweet_id": "1296690524590682112"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "562200134"}, "tweet_id": "1296690725501964289"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "548757643"}, "tweet_id": "1296692077032595462"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2434323137"}, "tweet_id": "1296693559953969154"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "47328374"}, "tweet_id": "1296731411769155590"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "728638622"}, "tweet_id": "1296756414334066688"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "903987325"}, "tweet_id": "1296761052026277889"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "149989254"}, "tweet_id": "1296770895478951936"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1131143732185698304"}, "tweet_id": "1296804965378412546"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "18026170"}, "tweet_id": "1296810788766617601"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "151155911"}, "tweet_id": "1296819415615324160"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "294905883"}, "tweet_id": "1296819741844275203"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1180123356403834880"}, "tweet_id": "1296824569374871552"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "519636015"}, "tweet_id": "1296825391236018177"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1296829905343336450"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1296829927023693826"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "73102744"}, "tweet_id": "1296845947507441673"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3772580962"}, "tweet_id": "1296846070102794242"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "180759786"}, "tweet_id": "1296846394146381824"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1203495488999370752"}, "tweet_id": "1296846431974821888"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3115002771"}, "tweet_id": "1296846766890012673"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "732774741040320512"}, "tweet_id": "1296850974603182082"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1182328203765043200"}, "tweet_id": "1296851101564768256"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "599670352"}, "tweet_id": "1296851433782800386"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1259607297770356736"}, "tweet_id": "1296851599441174528"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "633891855"}, "tweet_id": "1296853973274566657"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1263037811181191169"}, "tweet_id": "1296854761661247489"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1159835254187810816"}, "tweet_id": "1296857431335669767"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "36761844"}, "tweet_id": "1296858678906232832"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "339986709"}, "tweet_id": "1296859143056359427"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "52037301"}, "tweet_id": "1296860958569181184"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "40312899"}, "tweet_id": "1296864200871092224"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "431940711"}, "tweet_id": "1296867542204637186"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1241413268062773249"}, "tweet_id": "1296867803321040897"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "431940711"}, "tweet_id": "1296868658644430849"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "132297131"}, "tweet_id": "1296872037684781064"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "963408855702089730"}, "tweet_id": "1296872490027880448"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "147716987"}, "tweet_id": "1296875073102643200"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2749202594"}, "tweet_id": "1296876065605001216"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "510816105"}, "tweet_id": "1296877536698347521"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1182478689843458050"}, "tweet_id": "1296878620246450182"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3290613233"}, "tweet_id": "1296879715714818050"}, {"license": "gnip", "citation_ids": [85041504, 88564054], "author": {"tweeter_id": "66077793"}, "tweet_id": "1296881877182160897"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2662139235"}, "tweet_id": "1296882994637090816"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "166165380"}, "tweet_id": "1296884586618802178"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "90665937"}, "tweet_id": "1296890563216777216"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3556031235"}, "tweet_id": "1296890653796859905"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1065353441881526273"}, "tweet_id": "1296892726110294016"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1097184456"}, "tweet_id": "1296896255877152770"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "72707451"}, "tweet_id": "1296898026682961921"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2241108109"}, "tweet_id": "1296899365945180160"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "97037997"}, "tweet_id": "1296900201563729922"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4727580359"}, "tweet_id": "1296905603634417664"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1244711417657376768"}, "tweet_id": "1296910235504979971"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "14465282"}, "tweet_id": "1296910410533048320"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "969043768098873344"}, "tweet_id": "1296910681703436288"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2947821593"}, "tweet_id": "1296910890407788546"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "864977018823131136"}, "tweet_id": "1296911609248403456"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "235133788"}, "tweet_id": "1296913581032833024"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "935180740068806656"}, "tweet_id": "1296914352382128130"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "74802341"}, "tweet_id": "1296916626034561028"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1180121568426565633"}, "tweet_id": "1296929323962847237"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1388252623"}, "tweet_id": "1296930346668359680"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1238756076532764672"}, "tweet_id": "1296936599759052805"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4924525720"}, "tweet_id": "1296941670613819392"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3893850623"}, "tweet_id": "1296947123087384582"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1712256542"}, "tweet_id": "1296949400586063872"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1231587270559490048"}, "tweet_id": "1296950236368252928"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3220814930"}, "tweet_id": "1296950472490639360"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1028413513885208578"}, "tweet_id": "1296955181226168321"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1146448109070966784"}, "tweet_id": "1296970677724086272"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2780654617"}, "tweet_id": "1296981399006781443"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "37044302"}, "tweet_id": "1296986739660251136"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "298662219"}, "tweet_id": "1296999257954811905"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "15297373"}, "tweet_id": "1297024805942812673"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1274728637703417856"}, "tweet_id": "1297031995969724417"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1102339769344892928"}, "tweet_id": "1297053214437761024"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "711767883542622208"}, "tweet_id": "1297104566039777281"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2527973556"}, "tweet_id": "1297140396930281473"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1197977076315426816"}, "tweet_id": "1297143813887139840"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1525352100"}, "tweet_id": "1297248494571401226"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "118569729"}, "tweet_id": "1297248631616135168"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "204030177"}, "tweet_id": "1297248833882202114"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "755331892216524801"}, "tweet_id": "1297248986156486663"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "214940391"}, "tweet_id": "1297248992997396483"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "750022995268296704"}, "tweet_id": "1297249011842404353"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "817444302813069312"}, "tweet_id": "1297249040485277696"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2597749982"}, "tweet_id": "1297249181485146112"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "184776110"}, "tweet_id": "1297249333155434502"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2902047526"}, "tweet_id": "1297249474734170113"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "155902465"}, "tweet_id": "1297249760022323202"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "864845192087703553"}, "tweet_id": "1297249883410186240"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1004724038"}, "tweet_id": "1297250031096008705"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2496422394"}, "tweet_id": "1297250162428059650"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "208166292"}, "tweet_id": "1297250377075765249"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1111016709337563136"}, "tweet_id": "1297250523641450503"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "306502500"}, "tweet_id": "1297250585004122113"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1092821852802740225"}, "tweet_id": "1297250697726042112"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1246608605014634501"}, "tweet_id": "1297250815787311104"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1138715645263196160"}, "tweet_id": "1297251002882695168"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1014555329714163713"}, "tweet_id": "1297251846835392518"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "349287474"}, "tweet_id": "1297252405860499457"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3639360197"}, "tweet_id": "1297252537360437248"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1248632624689668098"}, "tweet_id": "1297252667329314818"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1267547868304416770"}, "tweet_id": "1297252712485191682"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4834142363"}, "tweet_id": "1297252776012066820"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1161719326292004865"}, "tweet_id": "1297252855326408706"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1252655454595014664"}, "tweet_id": "1297252872808288259"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "728310664230473728"}, "tweet_id": "1297253016580558850"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "192009237"}, "tweet_id": "1297253166128529408"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "863312990"}, "tweet_id": "1297253201331314689"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "808773370175229956"}, "tweet_id": "1297253535390851076"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "173949010"}, "tweet_id": "1297254355456974851"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4863494476"}, "tweet_id": "1297254630271918081"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1255411430679023616"}, "tweet_id": "1297254783934509056"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2403021999"}, "tweet_id": "1297254926507216896"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "424526589"}, "tweet_id": "1297255430629011456"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1519328383"}, "tweet_id": "1297255905608835072"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "855291012788269057"}, "tweet_id": "1297256093089964032"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3049338739"}, "tweet_id": "1297256638076915723"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1278447535120617473"}, "tweet_id": "1297256718687252482"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1039194570230300677"}, "tweet_id": "1297256870558806017"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1150778224613441536"}, "tweet_id": "1297256962762186754"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "755733606228779008"}, "tweet_id": "1297257495149318145"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "301361568"}, "tweet_id": "1297257917176057863"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "795737978840682497"}, "tweet_id": "1297257953884594178"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1048704483033829376"}, "tweet_id": "1297258442219048960"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1028737565447335937"}, "tweet_id": "1297258580480065542"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "253480651"}, "tweet_id": "1297258604018507776"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2754165582"}, "tweet_id": "1297259985286713344"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1282968658382409729"}, "tweet_id": "1297260949477494787"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "934531443774185472"}, "tweet_id": "1297260989017133058"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "795981064749678592"}, "tweet_id": "1297261525300903936"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3302019765"}, "tweet_id": "1297262003430526977"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "405831777"}, "tweet_id": "1297262780114964480"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "550307716"}, "tweet_id": "1297263067642953728"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "138889257"}, "tweet_id": "1297263682209091584"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "448801173"}, "tweet_id": "1297263788874518529"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "303456749"}, "tweet_id": "1297264126180429833"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1218644342933479429"}, "tweet_id": "1297264984926359552"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "444072315"}, "tweet_id": "1297265087821090816"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1232333174379773952"}, "tweet_id": "1297265227189420032"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2822192422"}, "tweet_id": "1297265662797254657"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "304457332"}, "tweet_id": "1297266225001758721"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1110191021382615040"}, "tweet_id": "1297266236913524738"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "979784467349950465"}, "tweet_id": "1297266771909644288"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "474699827"}, "tweet_id": "1297266833708507142"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "488366626"}, "tweet_id": "1297267277562347520"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "275979326"}, "tweet_id": "1297267735018311686"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "946370221"}, "tweet_id": "1297268224195690496"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1249011560053387265"}, "tweet_id": "1297268505595781126"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "882525569145077761"}, "tweet_id": "1297268546377003013"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1225032803445891073"}, "tweet_id": "1297268669895053314"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1063878051103219712"}, "tweet_id": "1297269420046323713"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3046969126"}, "tweet_id": "1297269944258895875"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1068294040301551622"}, "tweet_id": "1297269986596212736"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "81685587"}, "tweet_id": "1297270058381705220"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "375787333"}, "tweet_id": "1297270330105397248"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1063342718875828224"}, "tweet_id": "1297270469272440834"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "76414743"}, "tweet_id": "1297270545717907456"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "503136868"}, "tweet_id": "1297271383110692867"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1113915004355530758"}, "tweet_id": "1297271503373905920"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1482269718"}, "tweet_id": "1297271659842473985"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "206587301"}, "tweet_id": "1297272329396002816"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2302974733"}, "tweet_id": "1297273052846325760"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "40552769"}, "tweet_id": "1297273603457785857"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "352443395"}, "tweet_id": "1297273741785931779"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "32358134"}, "tweet_id": "1297273985982504961"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1110935794385072128"}, "tweet_id": "1297274560350429193"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1094322026184097797"}, "tweet_id": "1297275406760976384"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "585898139"}, "tweet_id": "1297275733660839942"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "924213401425010690"}, "tweet_id": "1297275822009712640"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "95513852"}, "tweet_id": "1297277652504662016"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "84792749"}, "tweet_id": "1297277674193379329"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2531729746"}, "tweet_id": "1297281497666396160"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "560193293"}, "tweet_id": "1297283142408118281"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "901453125726457860"}, "tweet_id": "1297283559535841281"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1259465516126810112"}, "tweet_id": "1297284665968033799"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1496957144"}, "tweet_id": "1297285988486709250"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "117817732"}, "tweet_id": "1297286627799306240"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1296160822180413440"}, "tweet_id": "1297287331272171523"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2232181917"}, "tweet_id": "1297290991087620096"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1250483697528320002"}, "tweet_id": "1297291349780299776"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2941339037"}, "tweet_id": "1297291995061387266"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1475280614"}, "tweet_id": "1297292866415468544"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3422820371"}, "tweet_id": "1297295055196127233"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3789515415"}, "tweet_id": "1297296029398818816"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1049288179830980608"}, "tweet_id": "1297296094376996874"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "804809714357956608"}, "tweet_id": "1297296251977977858"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1295039125372968973"}, "tweet_id": "1297296671005708290"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1118584303456333825"}, "tweet_id": "1297297115606130689"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1062768145809768449"}, "tweet_id": "1297297648949526530"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "747695089"}, "tweet_id": "1297297824439324673"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "254169307"}, "tweet_id": "1297301984865914885"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "807838356554022912"}, "tweet_id": "1297304524634361856"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1049774527981527041"}, "tweet_id": "1297304648878116864"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1036360777517723648"}, "tweet_id": "1297307133126598656"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "757652043561574404"}, "tweet_id": "1297310330876502016"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "987045081424244736"}, "tweet_id": "1297310341706260487"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2972993291"}, "tweet_id": "1297311601813577728"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "127692938"}, "tweet_id": "1297312904992239618"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2891792019"}, "tweet_id": "1297315405934014465"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2283398851"}, "tweet_id": "1297319435666100226"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1111771090181857280"}, "tweet_id": "1297319878840520705"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "767301440192872448"}, "tweet_id": "1297332137125912576"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1011367820620451845"}, "tweet_id": "1297341069672230912"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3034896813"}, "tweet_id": "1297342524567191555"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2469080337"}, "tweet_id": "1297360807064481792"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "720358958"}, "tweet_id": "1297362188634554369"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1148670799714369541"}, "tweet_id": "1297369212839755777"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1157880569340055552"}, "tweet_id": "1297374488120692736"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1058029551169740805"}, "tweet_id": "1297383600925671425"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "401525210"}, "tweet_id": "1297392765391777795"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1172934864447901696"}, "tweet_id": "1297393009080795136"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "139043353"}, "tweet_id": "1297395874419675136"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "241606353"}, "tweet_id": "1297397549146439680"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2667288420"}, "tweet_id": "1297397687499849730"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "930420036560408576"}, "tweet_id": "1297399052997464064"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1495165597"}, "tweet_id": "1297400619175739392"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "94649416"}, "tweet_id": "1297400822628843520"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3338530271"}, "tweet_id": "1297401304323690496"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1208671285670268928"}, "tweet_id": "1297402490875514890"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4032813263"}, "tweet_id": "1297402674183385089"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "759865372065472525"}, "tweet_id": "1297412583947894784"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2930336703"}, "tweet_id": "1297413782021513216"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "263590482"}, "tweet_id": "1297414438027485184"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "890674171642081281"}, "tweet_id": "1297416654499000320"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "75375144"}, "tweet_id": "1297418130688532480"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "106432316"}, "tweet_id": "1297420180566478848"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1226751428762439681"}, "tweet_id": "1297420776161910787"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "275687697"}, "tweet_id": "1297421527298834438"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1472555641"}, "tweet_id": "1297424108918116352"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1189620552471855104"}, "tweet_id": "1297426577622478851"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "331584215"}, "tweet_id": "1297427385487364096"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "336164002"}, "tweet_id": "1297429524695650304"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "341681745"}, "tweet_id": "1297430860455698432"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1449769436"}, "tweet_id": "1297431399570509829"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1239946236221968384"}, "tweet_id": "1297436555108384768"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2950983767"}, "tweet_id": "1297438005821607936"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "307012128"}, "tweet_id": "1297443114882404353"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "291083442"}, "tweet_id": "1297444640711376896"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1125481111411470338"}, "tweet_id": "1297444763063455747"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1009495052"}, "tweet_id": "1297448943408877568"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "163844377"}, "tweet_id": "1297452917436424194"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "466974801"}, "tweet_id": "1297453173066682369"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1203956686911881217"}, "tweet_id": "1297456716414582785"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1088462145283608576"}, "tweet_id": "1297457171534422016"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "166265422"}, "tweet_id": "1297457360227766273"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "452250047"}, "tweet_id": "1297457862470438912"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2375139632"}, "tweet_id": "1297462152165498880"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1704993026"}, "tweet_id": "1297468857146322944"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2247095084"}, "tweet_id": "1297470600106082314"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1047917983321006080"}, "tweet_id": "1297470844512468992"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "375230655"}, "tweet_id": "1297470875759980545"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "332429531"}, "tweet_id": "1297483038864146432"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "134841926"}, "tweet_id": "1297485226852200448"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "22190118"}, "tweet_id": "1297487538417012736"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1509472268"}, "tweet_id": "1297489636638502913"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "357086644"}, "tweet_id": "1297494755849404416"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "477555368"}, "tweet_id": "1297496302893359104"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1129314772380540930"}, "tweet_id": "1297496928620617728"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3392511557"}, "tweet_id": "1297497726356197377"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1164305723242815490"}, "tweet_id": "1297498475634941952"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3835517837"}, "tweet_id": "1297498590995197952"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "387561075"}, "tweet_id": "1297498713326313472"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "413791598"}, "tweet_id": "1297506066926833666"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1119330918"}, "tweet_id": "1297508571555471360"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "923271949090021376"}, "tweet_id": "1297509257231958017"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1217857332111122433"}, "tweet_id": "1297519720481132550"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "58253374"}, "tweet_id": "1297526651983724544"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1158161234644152322"}, "tweet_id": "1297528483304923138"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "830830778166673408"}, "tweet_id": "1297534808088875009"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2875198882"}, "tweet_id": "1297546714782498817"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "719186677198028800"}, "tweet_id": "1297547067267719169"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3457454836"}, "tweet_id": "1297547116307513345"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "113885051"}, "tweet_id": "1297555941588717569"}, {"license": "gnip", "citation_ids": [85041504, 88564054], "author": {"tweeter_id": "95750828"}, "tweet_id": "1297561599855726594"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1525352100"}, "tweet_id": "1297563905489866756"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3340695820"}, "tweet_id": "1297565968265351168"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "401525210"}, "tweet_id": "1297567386376327168"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "977969778"}, "tweet_id": "1297571029850742787"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "336435770"}, "tweet_id": "1297573165548306433"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "466974801"}, "tweet_id": "1297575680532779010"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1369343636"}, "tweet_id": "1297578422496092161"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1157777318405971968"}, "tweet_id": "1297578797798219776"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "97624659"}, "tweet_id": "1297578986231521280"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1251994807012151298"}, "tweet_id": "1297583014290100227"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3050633503"}, "tweet_id": "1297584029181640705"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2232181917"}, "tweet_id": "1297596058948771841"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "635798187"}, "tweet_id": "1297596936640503808"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "929108579617005568"}, "tweet_id": "1297600015154782209"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "613238326"}, "tweet_id": "1297602254766321669"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1212796155429437440"}, "tweet_id": "1297605773737033728"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2276427942"}, "tweet_id": "1297619049808039938"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "716598361"}, "tweet_id": "1297628174340296704"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "759669595510898688"}, "tweet_id": "1297630902110085120"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1140997751712428032"}, "tweet_id": "1297632898137436160"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "822877870854963201"}, "tweet_id": "1297645699916541953"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1241629035291164672"}, "tweet_id": "1297651092952686593"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "93499827"}, "tweet_id": "1297651513305845761"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "150307358"}, "tweet_id": "1297651736975376384"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "783785310358470656"}, "tweet_id": "1297655390415593472"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1219890686"}, "tweet_id": "1297655728891715585"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1141229610681679873"}, "tweet_id": "1297660725993799682"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "855208521478090753"}, "tweet_id": "1297664253860753410"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1140732406204424193"}, "tweet_id": "1297668328568299521"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1179789427108909056"}, "tweet_id": "1297676471935348737"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1246196671626776576"}, "tweet_id": "1297725518838726656"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "122876799"}, "tweet_id": "1297746052553027584"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "705863828412743680"}, "tweet_id": "1297774746604580864"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1039194570230300677"}, "tweet_id": "1297777361224695809"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "117817732"}, "tweet_id": "1297782173848809473"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "93257648"}, "tweet_id": "1297783263596023808"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3292243466"}, "tweet_id": "1297783488968568837"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "779015743677599745"}, "tweet_id": "1297786575187738624"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2970545145"}, "tweet_id": "1297793239634911232"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2970545145"}, "tweet_id": "1297793320475918336"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2426105868"}, "tweet_id": "1297808056185688064"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "865525910174171137"}, "tweet_id": "1297819327316533248"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "275745405"}, "tweet_id": "1297820774565388288"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "845120633369378816"}, "tweet_id": "1297824165676949506"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "720309779512565760"}, "tweet_id": "1297825173589172225"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2406666078"}, "tweet_id": "1297870677580578816"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "705915460693401600"}, "tweet_id": "1297871250002448384"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "123977488"}, "tweet_id": "1297885520777940995"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1345088989"}, "tweet_id": "1297944046091018240"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "435249416"}, "tweet_id": "1297983326003900418"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1046506973892685824"}, "tweet_id": "1298010184267247617"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "587497597"}, "tweet_id": "1298079440791117827"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "836998449014898689"}, "tweet_id": "1298119095561392129"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "185356861"}, "tweet_id": "1298176097926799361"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1202349757655592961"}, "tweet_id": "1298244561333084161"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "795630211"}, "tweet_id": "1298333044961619970"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2712748210"}, "tweet_id": "1298369195567087617"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2610505010"}, "tweet_id": "1298606693375447041"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "112249236"}, "tweet_id": "1298741656431329280"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2847920940"}, "tweet_id": "1299255183512203270"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1295295299225870336"}, "tweet_id": "1299595578146516993"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1299679525438136320"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1299679547110100992"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1015885898636902400"}, "tweet_id": "1300083411625717762"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "66077793"}, "tweet_id": "1302456499680100358"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1874866345"}, "tweet_id": "1302461623999672325"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "158234768"}, "tweet_id": "1302461977407533057"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1194915223079047168"}, "tweet_id": "1302462598911127553"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "286172113"}, "tweet_id": "1302463342074757120"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "155209803"}, "tweet_id": "1302463491240943617"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1245353252423516160"}, "tweet_id": "1302493620650389505"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "269216825"}, "tweet_id": "1302731180727435264"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2381642850"}, "tweet_id": "1303569088262803459"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1241719363922726919"}, "tweet_id": "1303656906574135296"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "53575911"}, "tweet_id": "1304944087502651392"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "704282873231237121"}, "tweet_id": "1305511184678948866"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "927131488050495488"}, "tweet_id": "1305598301861867522"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1280878711454273543"}, "tweet_id": "1306779177861951489"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1187962206970793984"}, "tweet_id": "1307789882677370880"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "367691029"}, "tweet_id": "1307850428541882369"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "203057638"}, "tweet_id": "1307878108515594241"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "260074082"}, "tweet_id": "1308053756492218370"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "44438256"}, "tweet_id": "1308104178703757312"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1389498121"}, "tweet_id": "1310333112740646913"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1167704263692312576"}, "tweet_id": "1310333921213767683"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1248268321251876866"}, "tweet_id": "1310339823476056065"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "704282873231237121"}, "tweet_id": "1310422341898379264"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "747327834494898176"}, "tweet_id": "1310427066618310657"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2376561452"}, "tweet_id": "1310427746762403841"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4749371428"}, "tweet_id": "1310437102174302208"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "259871223"}, "tweet_id": "1310519638535614469"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1066275282653536256"}, "tweet_id": "1310520891118366722"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2490709302"}, "tweet_id": "1310536939293028357"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "810995201112231940"}, "tweet_id": "1310563793060200448"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "29820543"}, "tweet_id": "1310616388067680256"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "147756414"}, "tweet_id": "1310643848809533455"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "406388619"}, "tweet_id": "1310738704734904320"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "343728470"}, "tweet_id": "1310758844721696769"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "132934212"}, "tweet_id": "1310768075105595392"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1137735120755077120"}, "tweet_id": "1310816887694073856"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "97507101"}, "tweet_id": "1310869146826166276"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "20627896"}, "tweet_id": "1310879599610523648"}, {"license": "gnip", "citation_ids": [91454862, 88564054], "author": {"tweeter_id": "66077793"}, "tweet_id": "1312190447633063936"}, {"license": "gnip", "citation_ids": [91454862, 88564054], "author": {"tweeter_id": "1080003527387287552"}, "tweet_id": "1312193331221331969"}, {"license": "gnip", "citation_ids": [91454862, 88564054], "author": {"tweeter_id": "269216825"}, "tweet_id": "1312200076933001216"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2391249467"}, "tweet_id": "1313226166719873025"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1256690178342686721"}, "tweet_id": "1313543965988196353"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1244761670569922560"}, "tweet_id": "1314523982247460867"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1244761670569922560"}, "tweet_id": "1314524044486758400"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "939905466280357893"}, "tweet_id": "1314533914283737089"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "269513439"}, "tweet_id": "1317126055497519105"}, {"license": "gnip", "citation_ids": [85041504, 88564054], "author": {"tweeter_id": "198957675"}, "tweet_id": "1317334379027255296"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "198957675"}, "tweet_id": "1317334521876893696"}, {"license": "gnip", "citation_ids": [88564054, 92401921], "author": {"tweeter_id": "66077793"}, "tweet_id": "1317691954419757056"}, {"license": "gnip", "citation_ids": [88564054, 92401921], "author": {"tweeter_id": "100420386"}, "tweet_id": "1318431038880710657"}, {"license": "gnip", "citation_ids": [88564054, 92401921], "author": {"tweeter_id": "2676500635"}, "tweet_id": "1318515979710681093"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "585807608"}, "tweet_id": "1325797849351790594"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "701764234217189376"}, "tweet_id": "1325801713236840451"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2470050275"}, "tweet_id": "1325802145032130561"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "932382617336508416"}, "tweet_id": "1325802531491094528"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4190743174"}, "tweet_id": "1325802766065864704"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2704718926"}, "tweet_id": "1325802852523118592"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "984172899308392448"}, "tweet_id": "1325803738817294337"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4445253628"}, "tweet_id": "1325804467321794560"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "21242028"}, "tweet_id": "1325804601505951744"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "157295110"}, "tweet_id": "1325804781747761152"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "580411725"}, "tweet_id": "1325806039606960128"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1101288661834915840"}, "tweet_id": "1325806297401454592"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "19741485"}, "tweet_id": "1325806559608385537"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2824672746"}, "tweet_id": "1325807448402386945"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3782572522"}, "tweet_id": "1325808428443381760"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3102300361"}, "tweet_id": "1325809538956742657"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "404377878"}, "tweet_id": "1325809665717006338"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1287063033248993280"}, "tweet_id": "1325810056902881280"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "876005676547309568"}, "tweet_id": "1325812004624347138"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "88078502"}, "tweet_id": "1325816007416537088"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3378279069"}, "tweet_id": "1325824893494157314"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1069708722325213184"}, "tweet_id": "1325832432831123456"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1198591504895422466"}, "tweet_id": "1325838980336717827"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2670779328"}, "tweet_id": "1325848067073994752"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2770666612"}, "tweet_id": "1325849473642352645"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "250803178"}, "tweet_id": "1325853218849640450"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1029137666132992000"}, "tweet_id": "1325857175420325888"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "883785404389961728"}, "tweet_id": "1325857516195115008"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2181077592"}, "tweet_id": "1325867055581630465"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "268482196"}, "tweet_id": "1325874434343923714"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "96874423"}, "tweet_id": "1325876678187491328"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1110928426444251137"}, "tweet_id": "1325877031507202049"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3166329193"}, "tweet_id": "1325877642910896128"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "36761844"}, "tweet_id": "1325878664127451137"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "25997546"}, "tweet_id": "1325886434511892480"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "52087699"}, "tweet_id": "1325889448261849089"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "465562896"}, "tweet_id": "1325899913088077828"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "241093820"}, "tweet_id": "1325900024266575873"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "304576865"}, "tweet_id": "1325902668322250754"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "190648628"}, "tweet_id": "1325910400928526336"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "749385441921544192"}, "tweet_id": "1325918745294999552"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "824524105831612416"}, "tweet_id": "1325933018616377352"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2713172484"}, "tweet_id": "1325939839934619649"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "15626406"}, "tweet_id": "1325942432089829377"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "756532137210281984"}, "tweet_id": "1325942999587704833"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2889735293"}, "tweet_id": "1325963596568940546"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "191501637"}, "tweet_id": "1325967584211165185"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "245228514"}, "tweet_id": "1325996271836884992"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1280878711454273543"}, "tweet_id": "1325997224648642563"}, {"license": "gnip", "citation_ids": [86123198, 85041504, 88564054], "author": {"tweeter_id": "296476788"}, "tweet_id": "1326065377403678720"}, {"license": "gnip", "citation_ids": [86123198, 85041504, 88564054], "author": {"tweeter_id": "296476788"}, "tweet_id": "1326070958638116864"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "49669486"}, "tweet_id": "1326144804166770688"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "20085499"}, "tweet_id": "1326149502923923458"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "25290877"}, "tweet_id": "1326149940989530116"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "63275377"}, "tweet_id": "1326165322009882625"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "252518236"}, "tweet_id": "1326181558282280960"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "63275377"}, "tweet_id": "1326217711748321280"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "63275377"}, "tweet_id": "1326260876496822273"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "63275377"}, "tweet_id": "1326263542295695378"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "364476368"}, "tweet_id": "1326263990272536580"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "76270569"}, "tweet_id": "1326265605926903809"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "63275377"}, "tweet_id": "1326266016607907843"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "15846507"}, "tweet_id": "1326268573711556608"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1863539299"}, "tweet_id": "1326271691731963906"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1439094972"}, "tweet_id": "1326384861159026690"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "797593858880270340"}, "tweet_id": "1326396577297133568"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1202160452127596544"}, "tweet_id": "1326401443176321026"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4885776645"}, "tweet_id": "1326485593023508480"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "112865297"}, "tweet_id": "1326565024220016643"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "63275377"}, "tweet_id": "1326574028610396160"}, {"license": "gnip", "citation_ids": [88564054, 92401921], "author": {"tweeter_id": "63275377"}, "tweet_id": "1326574482560065536"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2474383129"}, "tweet_id": "1326591568640405506"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "278613214"}, "tweet_id": "1326827232648683520"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "48315164"}, "tweet_id": "1326874994459070465"}, {"license": "gnip", "citation_ids": [88111868, 88564054], "author": {"tweeter_id": "405259665"}, "tweet_id": "1326933526667816965"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "223663798"}, "tweet_id": "1327104997096448001"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1178654157286383618"}, "tweet_id": "1327260506017714178"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1277970584949813249"}, "tweet_id": "1327262074641281024"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "38456071"}, "tweet_id": "1327263313730830338"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "634242289"}, "tweet_id": "1327427448506466305"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "22681424"}, "tweet_id": "1328055698048086020"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "167446775"}, "tweet_id": "1328059517528125441"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "60266138"}, "tweet_id": "1328084290064695296"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "833426782284046336"}, "tweet_id": "1328171479687630849"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "49344076"}, "tweet_id": "1328420817101860865"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1726901670"}, "tweet_id": "1328445773286170626"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "419256305"}, "tweet_id": "1328758555394985985"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "947998967991762944"}, "tweet_id": "1328812760625516555"}, {"license": "gnip", "citation_ids": [92401921, 88564054], "author": {"tweeter_id": "1321896390096756738"}, "tweet_id": "1328845852438355968"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2571192054"}, "tweet_id": "1329788718782230530"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "889570898566672386"}, "tweet_id": "1329874174425358340"}, {"license": "gnip", "citation_ids": [88564054, 88111868], "author": {"tweeter_id": "1541149375"}, "tweet_id": "1330065455130832898"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2476141399"}, "tweet_id": "1331310246887890949"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2476141399"}, "tweet_id": "1331310789865713669"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2476141399"}, "tweet_id": "1331310951719727106"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2476141399"}, "tweet_id": "1331313940392013828"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2476141399"}, "tweet_id": "1331314546724712449"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1256942387697528832"}, "tweet_id": "1331315146824818694"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1256942387697528832"}, "tweet_id": "1331315177959067653"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1003004687573020672"}, "tweet_id": "1331712351670853633"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1084872696003997698"}, "tweet_id": "1332015476000624642"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "48761781"}, "tweet_id": "1332698947656314880"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "51465178"}, "tweet_id": "1332818325810900996"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "112106389"}, "tweet_id": "1333449477173067781"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "822357992049778689"}, "tweet_id": "1333451895176773641"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2694328944"}, "tweet_id": "1333546385178648577"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "153375677"}, "tweet_id": "1334070011594493952"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "153375677"}, "tweet_id": "1334070150677590018"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "153375677"}, "tweet_id": "1334073627256496128"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "14797894"}, "tweet_id": "1334082276766969857"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1307757315043528706"}, "tweet_id": "1334083521674096641"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1249607420508286977"}, "tweet_id": "1334226734099607553"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "126081363"}, "tweet_id": "1335165920684085249"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "126081363"}, "tweet_id": "1335167815825895425"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "126081363"}, "tweet_id": "1335178017098895364"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "847847543753125893"}, "tweet_id": "1335232889206792192"}, {"license": "gnip", "citation_ids": [85041504, 88564054], "author": {"tweeter_id": "1399840284"}, "tweet_id": "1335496555776909313"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "287861333"}, "tweet_id": "1335555312292655104"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2836710505"}, "tweet_id": "1335650248090333186"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1643635238"}, "tweet_id": "1335686370606653442"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "368328534"}, "tweet_id": "1336366672786157570"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1303788612266471434"}, "tweet_id": "1336371983760707588"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "956496740688871424"}, "tweet_id": "1336486460933988354"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2318991212"}, "tweet_id": "1336487059918368770"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "720655669813075968"}, "tweet_id": "1336489171993513985"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "16551001"}, "tweet_id": "1336658764561313793"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1702535485"}, "tweet_id": "1336683452431790085"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1071748105488486401"}, "tweet_id": "1336713757498675200"}, {"license": "gnip", "citation_ids": [89687303, 88564054], "author": {"tweeter_id": "419517624"}, "tweet_id": "1336868959946215424"}, {"license": "gnip", "citation_ids": [89687303, 88564054], "author": {"tweeter_id": "2405162058"}, "tweet_id": "1336925530847924229"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "63275377"}, "tweet_id": "1337091015212150787"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "88175494"}, "tweet_id": "1337572473173278720"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "59257180"}, "tweet_id": "1338224898725064708"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "824524105831612416"}, "tweet_id": "1338440708483637248"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1340694122466828291"}, "tweet_id": "1340792301765967873"}, {"license": "gnip", "citation_ids": [88564054, 86123198, 85041504], "author": {"tweeter_id": "4714522594"}, "tweet_id": "1344608289770917888"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2635505990"}, "tweet_id": "1344692723241123842"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1280878711454273543"}, "tweet_id": "1344693931171319808"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "2732631933"}, "tweet_id": "1344733496594620417"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "282914879"}, "tweet_id": "1344962948968697857"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "21219103"}, "tweet_id": "1344968827600334855"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "935516699859746816"}, "tweet_id": "1344991141993844737"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "741677155214561280"}, "tweet_id": "1344998957051768833"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "925850513761030149"}, "tweet_id": "1345025474603462656"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "14465282"}, "tweet_id": "1345099493671272448"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4675263566"}, "tweet_id": "1345337561091198976"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "282914879"}, "tweet_id": "1345347871885979650"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "75072295"}, "tweet_id": "1345347986554056704"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4832862820"}, "tweet_id": "1345352746543800320"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "751902402735906816"}, "tweet_id": "1345353768767025154"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "315201855"}, "tweet_id": "1345355825842446336"}, {"license": "gnip", "citation_ids": [88564054, 86123198, 85041504], "author": {"tweeter_id": "4865573865"}, "tweet_id": "1345636203345960963"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1315158928200732673"}, "tweet_id": "1346392978030526466"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1315158928200732673"}, "tweet_id": "1346393302824853505"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "708203274495791104"}, "tweet_id": "1346798226310107138"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4347061"}, "tweet_id": "1346840015540793347"}, {"license": "gnip", "citation_ids": [88564054, 92401921], "author": {"tweeter_id": "1221358388094828544"}, "tweet_id": "1348350679253983235"}, {"license": "gnip", "citation_ids": [95765100, 88564054], "author": {"tweeter_id": "1249373565515857926"}, "tweet_id": "1348746359810236428"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "107231772"}, "tweet_id": "1348946364219187200"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1477127906"}, "tweet_id": "1357434526666997761"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1215444012322172928"}, "tweet_id": "1358829666983841799"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1280878711454273543"}, "tweet_id": "1358830250902253568"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "257971747"}, "tweet_id": "1358919885472997376"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4222704353"}, "tweet_id": "1359237169349603330"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "400413662"}, "tweet_id": "1360387786096926720"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "3407657733"}, "tweet_id": "1362126693553623046"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "873268395583602692"}, "tweet_id": "1363539171558764546"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1366541711590105092"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1046451967"}, "tweet_id": "1372149452295790595"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "4091755695"}, "tweet_id": "1370816712312909825"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "15271509"}, "tweet_id": "1378633119360778242"}, {"license": "gnip", "citation_ids": [88564054], "author": {"tweeter_id": "1132559626065592321"}, "tweet_id": "1380535390143139846"}, {"license": "gnip", "citation_ids": [93995191, 88564054], "author": {"tweeter_id": "1230106474568986624"}, "tweet_id": "1387673458302230531"}, {"license": "gnip", "citation_ids": [93995191, 88564054], "author": {"tweeter_id": "1372598064901410816"}, "tweet_id": "1387813388735197186"}], "news": [{"title": "News story from Stat News on Thursday 20 August 2020", "url": null, "license": "nla", "citation_ids": [88564054], "posted_on": "2020-08-20T14:30:44+00:00", "summary": null, "author": {"name": "Stat News", "url": "http://www.statnews.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/404/normal/Screen_Shot_2015-12-10_at_14.17.42.png?1449757087"}}, {"title": "Pfizer/BioNTech pivot to new COVID-19 vaccine candidate with better safety profile", "url": "http://ct.moreover.com/?a=42883510638&p=1pl&v=1&x=4iWHB7n92Tihz5I46sr59g", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T10:58:53+00:00", "summary": "Pfizer (PFE +0.3%) and development partner BioNTech SE (BNTX +2.3%) are proceeding with a large-scale Phase 3 clinical trial evaluating its newly annointed top COVID-19 vaccine candidate, BNT162b2.", "author": {"name": "Seeking Alpha", "url": "http://seekingalpha.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/665/normal/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336"}}, {"title": "News story from Daily Mail on Thursday 20 August 2020", "url": null, "license": "nla", "citation_ids": [88564054], "posted_on": "2020-08-20T20:50:30+00:00", "summary": null, "author": {"name": "Daily Mail", "url": "http://www.dailymail.co.uk", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/002/normal/image.png?1369859436"}}, {"title": "Coronavirus: Pfizer's second vaccine has fewer side effects - NewsyPeople", "url": "https://newsypeople.com/2020/08/20/coronavirus-pfizers-second-vaccine-has-fewer-side-effects/?utm_source=rss&utm_medium=rss&utm_campaign=coronavirus-pfizers-second-vaccine-has-fewer-side-effects", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T20:53:39+00:00", "summary": "The experimental coronavirus vaccine currently being tested by Pfizer Inc and its German partner BioNTech is more promising than the one on which results were presented last month.", "author": {"name": "NewsyPeople", "url": "https://www.newsypeople.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/979/normal/21.JPG?1578544803"}}, {"title": "Coronavirus: Pfizer\u2019s second vaccine has fewer side effects", "url": "http://ct.moreover.com/?a=42885682295&p=1pl&v=1&x=AJ1y8mIQ3DGNsKAnpQNyDg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T20:50:30+00:00", "summary": "Pfizer\u2019s second experimental coronavirus vaccine left HALF as many people with side effects compared to its first in a promising sign for a safe shot Both vaccines use part of the coronavirus\u2019s genetic code.", "author": {"name": "Readsector", "url": "https://readsector.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/005/532/normal/Screen_Shot_2020-07-10_at_16.45.38.png?1594392794"}}, {"title": "Coronavirus: Pfizer's second vaccine has fewer side effects", "url": "http://ct.moreover.com/?a=42885747616&p=1pl&v=1&x=zsd37Drsw-F34CcILDPjyg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T21:04:56+00:00", "summary": "The experimental coronavirus vaccine currently being tested by Pfizer Inc and its German partner BioNTech is more promising than the one on which results were presented last month.", "author": {"name": "The Amed Post", "url": "https://amedpost.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/302/normal/post.png?1574839885"}}, {"title": "Pfizer's second coronavirus jab has fewer side effects than the first", "url": "http://ct.moreover.com/?a=42886051433&p=1pl&v=1&x=CYoYIdA-WyfYVU2mqMi0_w", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T21:57:53+00:00", "summary": "The experimental coronavirus vaccine currently being tested by Pfizer Inc and its German partner BioNTech is more promising than the one on which results were presented last month.", "author": {"name": "MSN", "url": "http://www.msn.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/360/normal/Screen_Shot_2016-01-06_at_15.14.19.png?1452093279"}}, {"title": "Pfizer's second coronavirus jab has fewer side effects than the first", "url": "http://ct.moreover.com/?a=42886180679&p=1pl&v=1&x=uPmRiMKMeba5x-xez2PHQQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T22:20:20+00:00", "summary": "The experimental coronavirus vaccine currently being tested by Pfizer Inc and its German partner BioNTech is more promising than the one on which results were presented last month.", "author": {"name": "Pressfrom", "url": "https://pressfrom.info", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/169/normal/Screenshot_2019-08-08_at_15.06.30.png?1565273214"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886760362&p=1pl&v=1&x=12ToZjhxeCY-H1hHg3Tf6A", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:00:00+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30 \u03bcg, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Business Wire", "url": "http://www.businesswire.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/867/normal/Screen_Shot_2016-01-27_at_12.24.36.png?1453897504"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886745899&p=1pl&v=1&x=XtQuZgNKfkvwvn5vODY4eg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:02:53+00:00", "summary": "NEW YORK & MAINZ, Germany--(Business Wire)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and immunogenicity data from their ongoing U.S.", "author": {"name": "Digital Journal", "url": "http://www.digitaljournal.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/223/normal/image.png?1371424893"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886746966&p=1pl&v=1&x=HrRpjkkMmTquiURxYm6H_Q", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:02:28+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30\u03bcg, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "DMN Newswire!", "url": "http://dmnnewswire.digitalmedianet.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/925/normal/Screen_Shot_2018-09-17_at_18.46.43.png?1537206495"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886752595&p=1pl&v=1&x=Gx5QS0fONhHsAFBrwHkn3Q", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:03:29+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30 \u03bcg, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Stockwatch", "url": "https://www.stockwatch.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/797/normal/Capture19.PNG?1576480973"}}, {"title": "News story from Finanz Nachrichten on Friday 21 August 2020", "url": null, "license": "nla", "citation_ids": [88564054], "posted_on": "2020-08-21T00:29:00+00:00", "summary": null, "author": {"name": "Finanz Nachrichten", "url": "http://www.finanznachrichten.de", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/853/normal/Screen_Shot_2016-01-27_at_11.54.22.png?1453895724"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886852932&p=1pl&v=1&x=tMn4hgZNYzpRdXMeA-rW6g", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:29+00:00", "summary": "BioNTech SE ADR-Aktie dauerhaft f\u00fcr 0 Euro handeln! Jetzt auf Smartbroker.de In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years\u2026", "author": {"name": "Ariva", "url": "http://www.ariva.de", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/907/normal/Screen_Shot_2016-01-27_at_14.41.07.png?1453905685"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886786328&p=1pl&v=1&x=U22ZPfw1zD0Rwv84zsvkwA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:00:00+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30 \u03bcg, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Morning Star", "url": "https://www.morningstar.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/912/normal/Screen_Shot_2018-09-17_at_18.20.59.png?1537204915"}}, {"title": "Pfizer And BioNTech Share Positive Early Data On Lead MRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886788206&p=1pl&v=1&x=IGs3JHiL4rhtZ3CbjFy2xw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:00:00+00:00", "summary": "Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and immunogenicity data from their ongoing U.", "author": {"name": "The Street", "url": "http://www.thestreet.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/809/normal/Screen_Shot_2016-01-27_at_10.05.56.png?1453889412"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886887029&p=1pl&v=1&x=r8XjVJtfCaDbwCsIBrp3NA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:29+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Benzinga", "url": "http://www.benzinga.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/738/normal/Screen_Shot_2016-01-26_at_15.59.27.png?1453824001"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886837228&p=1pl&v=1&x=iFBbeysYC0CC5HiLUmxugA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:00:00+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "GlobeNewswire", "url": "https://www.globenewswire.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/389/normal/B.PNG?1575002884"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886850019&p=1pl&v=1&x=MdYmhB1blQeLADoTk51HRw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:20:38+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Crwe World", "url": "http://crweworld.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/344/normal/Capture_crwe.PNG?1574923200"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886853577&p=1pl&v=1&x=kBeUE1h73wGJWOMaBts4dg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:22:15+00:00", "summary": "NEW YORK and MAINZ, Germany, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and immunogenicity data from their ongoing U.S.", "author": {"name": "Finanzen", "url": "https://www.finanzen.at/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/571/normal/Capture25.PNG?1575885785"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on \u2026", "url": "http://ct.moreover.com/?a=42887257785&p=1pl&v=1&x=GQ3p4fw8TqUejpZk9UDbkw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T01:48:11+00:00", "summary": "] In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "TMCnet.com", "url": "http://www.tmcnet.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/169/normal/Screen_Shot_2014-10-01_at_14.45.46.png?1412171168"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886861506&p=1pl&v=1&x=pDaLUkPA4fx-gWMF7SIJBA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:29+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Finanzen.ch", "url": "https://www.finanzen.ch/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/573/normal/Capture26.PNG?1575886265"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886879794&p=1pl&v=1&x=DwLIMkozfc93ZugHe1sS9w", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:27:22+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u00e2\u20ac\u201cneutralizing geometric mean titers (GMTs) in\u00c2 younger adults (18-55 years of age) that were 3.8 times the GMT of\u00c2 a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Biz Wire Express", "url": "http://www.bizwireexpress.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/795/normal/Screen_Shot_2016-01-27_at_09.34.21.png?1453887297"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886899812&p=1pl&v=1&x=pWhD1_fsKMDHMQcQhfwz4Q", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:00+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) inyounger adults (18-55 years of age) that were 3.8 times the GMT ofa panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Yahoo! News", "url": "http://news.yahoo.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/032/normal/yahoo_news.png?1369846922"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886908034&p=1pl&v=1&x=Mk279FkPQWTzplcpTxJibg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:01:03+00:00", "summary": "- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and immunogenicity data from their ongoing U.S.", "author": {"name": "KULR 8", "url": "https://www.kulr8.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/673/normal/Capture_kurl.PNG?1576137426"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886908597&p=1pl&v=1&x=3fL39nl_LAFJNXqgAqInqw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:19+00:00", "summary": "NEW YORK and MAINZ, Germany, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and immunogenicity data from their ongoing U.S.", "author": {"name": "PM 360", "url": "http://www.pm360online.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/739/normal/Screen_Shot_2016-02-02_at_17.08.15.png?1454432906"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886945161&p=1pl&v=1&x=wDfvWSLvDfNQtMXxv4cHTg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:40:29+00:00", "summary": "| Spoke  Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19 In a Phase 1 study in the U.S., at 7 days after a second dose of 30 \u03bcg, BNT162b2 elicited SARS-C\u2026", "author": {"name": "Spoke", "url": "http://www.spoke.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/787/normal/Capture14.PNG?1576476237"}}, {"title": "Pfizer and BioNTech's favored Covid-19 vaccine has fewer side effects than their first", "url": "http://ct.moreover.com/?a=42886963795&p=1pl&v=1&x=vo7jGFTeCzrB372-Cs-d1A", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:17:36+00:00", "summary": "Pfizer and BioNTech surprised many industry watchers on July 27 when they announced they would conduct a large-scale study of a vaccine for Covid-19.", "author": {"name": "CNBC", "url": "http://www.cnbc.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/411/normal/Screen_Shot_2016-01-12_at_14.43.08.png?1452609805"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886978399&p=1pl&v=1&x=6TLL7Lp_TWJODTFIMNX_2w", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:00+00:00", "summary": "-- In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug,BNT162b2elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Daily Journal (Tupelo)", "url": "https://www.djournal.com/"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886980945&p=1pl&v=1&x=yYkRbhFhhC4RKZ8op6-F8g", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:00+00:00", "summary": "-- In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug,BNT162b2elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Post Register", "url": "https://www.postregister.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/764/normal/register.PNG?1576239676"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42886996047&p=1pl&v=1&x=YwrSX9dvDcoAxQvELI9U1g", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:01:03+00:00", "summary": "- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and immunogenicity data from their ongoing U.S.", "author": {"name": "The Daily Times", "url": "https://www.thedailytimes.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/837/normal/Capture5.PNG?1576556700"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42887044355&p=1pl&v=1&x=LhkHFjhstWNsCe0yLD2ivg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T00:16:29+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "EINPresswire", "url": "https://www.einpresswire.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/542/normal/Capture12.PNG?1575872056"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42887101293&p=1pl&v=1&x=CL_j2Ko2T5GNJIikbubL5A", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T01:13:25+00:00", "summary": "Further, across all populations, BNT162b2 administration was well tolerated with mild to moderate fever in fewer than 20% of the participants.", "author": {"name": "Jotup", "url": "https://jotup.co/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/231/normal/jotup-logo.png?1567071493"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42887345844&p=1pl&v=1&x=00vRdXD6VefDYobUKZA2AQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T02:07:04+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "Shares Magazine", "url": "https://www.sharesmagazine.co.uk/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/769/normal/Capture5.PNG?1576470130"}}, {"title": "Pfizer, BioNTech Say Second Coronavirus Vaccine Shows Fewer Side Effects Than Their First Candidate", "url": "http://ct.moreover.com/?a=42887474976&p=1pl&v=1&x=SJHqI1lIuFm4qJJD8eHvTA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T02:27:07+00:00", "summary": "Pfizer Inc (NYSE: PFE ), and its partner BioNTech SE (NASDAQ: BNTX ), announced positive results for the Phase 1 trial of their second COVID-19 vaccine candidate, stating that the latest vaccine candidate had fewer side effects than their first.", "author": {"name": "Benzinga", "url": "http://www.benzinga.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/738/normal/Screen_Shot_2016-01-26_at_15.59.27.png?1453824001"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42887860261&p=1pl&v=1&x=-R3vuE2rG1xAyIYA4tnEvw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T03:46:27+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "ValueSpectrum", "url": "https://www.valuespectrum.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/836/normal/57.JPG?1576556484"}}, {"title": "Pfizer, BioNTech unveil data that gave partners their lead vaccine", "url": "https://www.biocentury.com/article/629646/pfizer-biontech-unveil-data-that-gave-partners-their-lead-vaccine", "license": "public", "citation_ids": [88564054, 88542572, 88476975], "posted_on": "2020-08-21T02:33:11+00:00", "summary": "Product Development Plus Novavax reports sterilizing immunity in second monkey model; Elicio unveils vaccine candidate Aug 21, 2020 | 2:33 AM GMT Pfizer and BioNTech have revealed the clinical data that led the partners to choose which vaccine they\u2026", "author": {"name": "BioCentury", "url": "http://www.biocentury.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/410/normal/Screen_Shot_2015-12-10_at_14.50.19.png?1449759038"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42888139323&p=1pl&v=1&x=YYZd7oCTWTuVBcDbhyVNfQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T04:48:26+00:00", "summary": "Aug. 21, 2020 00:00 UTC In a Phase 1 study in the U.S., at 7 days after a second dose of 30 \u03bcg, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of\u2026", "author": {"name": "Biospace", "url": "http://www.biospace.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/375/normal/biospace.png?1437140433"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42888311398&p=1pl&v=1&x=7ZZcuO48wzCE0s7GCTYYJw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T05:24:35+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "NASDAQ", "url": "http://www.nasdaq.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/839/normal/Screen_Shot_2016-01-27_at_11.14.52.png?1453893369"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42888752528&p=1pl&v=1&x=Gh0zw8xi9DC-oUd0ugDaag", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T06:42:36+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "BioTech Gate", "url": "http://www.biotechgate.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/835/normal/Screen_Shot_2016-01-27_at_11.07.21.png?1453892866"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42889007940&p=1pl&v=1&x=STRMPoo8uEOG-TqP2z4d4g", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T07:31:27+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "gurufocus", "url": "https://www.gurufocus.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/591/normal/7.JPG?1576044783"}}, {"title": "More Pfizer/BioNTech Data On Their Actual Vaccine Candidate", "url": "http://ct.moreover.com/?a=42889318085&p=1pl&v=1&x=TWvwnTdL-upFxQfQX-xIiQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T08:24:39+00:00", "summary": "Summary Pfizer/BioNTech released more data about their actual coronavirus vaccine candidate, BNT162b2.", "author": {"name": "Seeking Alpha", "url": "http://seekingalpha.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/665/normal/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336"}}, {"title": "Biontech und Pfizer: mRNA-Impfstoff \u00fcberzeugt in Phase I", "url": "http://ct.moreover.com/?a=42890267802&p=1pl&v=1&x=yj2I2XcIxnvHlEh2N8XYpQ", "license": "public", "citation_ids": [88564054, 80996494], "posted_on": "2020-08-21T09:30:00+00:00", "summary": "Die jetzt ver\u00f6ffentlichten Daten stammen aus einer Phase-I-Studie in den USA mit 195 Probanden.", "author": {"name": "Pharmazeutische Zeitung", "url": "http://www.pharmazeutische-zeitung.de/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/040/normal/Screen_Shot_2014-07-17_at_11.38.10.png?1405593576"}}, {"title": "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19", "url": "http://ct.moreover.com/?a=42890190471&p=1pl&v=1&x=LHA6ykCwkgyx08duxixjdA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T10:36:37+00:00", "summary": "In a Phase 1 study in the U.S., at 7 days after a second dose of 30ug, BNT162b2 elicited SARS-CoV-2\u2013neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2\u2026", "author": {"name": "PharmiWeb", "url": "https://www.pharmiweb.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/921/normal/Screen_Shot_2018-09-17_at_18.39.39.png?1537206114"}}, {"title": "Pfizer, BioNTech share clinical data linking favored COVID-19 vaccine to improved tolerability", "url": "https://www.fiercebiotech.com/biotech/pfizer-biontech-share-clinical-data-linking-favored-covid-19-vaccine-to-improved", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T12:56:07+00:00", "summary": "Pfizer and BioNTech have published clinical data on the COVID-19 vaccine they advanced into phase 3.", "author": {"name": "Fierce Biotech", "url": "http://www.fiercebiotech.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/239/normal/Screen_Shot_2016-02-25_at_15.13.22.png?1456413240"}}, {"title": "Pfizer, BioNTech Say Second Coronavirus Vaccine Shows Fewer Side Effects Than Their First Candidate Benzinga", "url": "http://ct.moreover.com/?a=42891460533&p=1pl&v=1&x=snas7TCA7hu6w2uDPrYTFg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T02:27:07+00:00", "summary": "Pfizer Inc (NYSE: ), and its partner BioNTech SE (NASDAQ: ), announced positive results for the Phase 1 trial of their second COVID-19 vaccine candidate, stating that the latest vaccine candidate had fewer side effects than their first.", "author": {"name": "Yahoo! Finance USA", "url": "http://finance.yahoo.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/620/normal/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}}, {"title": "This is the best news of the week about coronavirus vaccines", "url": "http://ct.moreover.com/?a=42892296336&p=1pl&v=1&x=yXg4JDoueZ9ixwEBdLyHYg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T15:32:48+00:00", "summary": "In a significant coronavirus vaccine update, Pfizer and BioNTech announced additional details about their experimental drug that has just started Phase 2/3 testing.", "author": {"name": "Bgr", "url": "https://bgr.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/592/normal/bgr.png?1570785355"}}, {"title": "Safer Pfizer COVID-19 mRNA Vax Candidate Moves Forward", "url": "http://ct.moreover.com/?a=42894306778&p=1pl&v=1&x=rQj9iKLUWpQ4hab-wwXuLQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T21:45:33+00:00", "summary": "Infectious Disease > COVID-19 Reactogenicity played large role in selection, full phase I data showed With the international collaboration between Pfizer and BioNTech yielding a modified RNA COVID-19 vaccine candidate to progress to phase II/III\u2026", "author": {"name": "MedPage Today", "url": "http://www.medpagetoday.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/262/normal/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}}, {"title": "Pfizer's second coronavirus jab has fewer side effects than the first", "url": "https://news.google.com/__i/rss/rd/articles/CBMigAFodHRwczovL3d3dy5kYWlseW1haWwuY28udWsvaGVhbHRoL2FydGljbGUtODY0ODQ2OS9QZml6ZXJzLWV4cGVyaW1lbnRhbC1zZWNvbmQtY29yb25hdmlydXMtdmFjY2luZS1mZXdlci1lZmZlY3RzLWphYi10ZXN0ZWQuaHRtbNIBhAFodHRwczovL3d3dy5kYWlseW1haWwuY28udWsvaGVhbHRoL2FydGljbGUtODY0ODQ2OS9hbXAvUGZpemVycy1leHBlcmltZW50YWwtc2Vjb25kLWNvcm9uYXZpcnVzLXZhY2NpbmUtZmV3ZXItZWZmZWN0cy1qYWItdGVzdGVkLmh0bWw?oc=5", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T20:50:30+00:00", "summary": "Pfizer's second experimental coronavirus vaccine left HALF as many people with side effects compared to its first in a promising sign for a safe shot Both vaccines use part of the coronavirus's genetic code.", "author": {"name": "Google News", "url": "http://news.google.co.uk/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/029/normal/image.png?1369860372"}}, {"title": "This is the best news of the week about coronavirus vaccines", "url": "https://news.google.com/__i/rss/rd/articles/CBMiWmh0dHBzOi8vYmdyLmNvbS8yMDIwLzA4LzIxL2Nvcm9uYXZpcnVzLXZhY2NpbmUtdXBkYXRlLXBmaXplci1iaW9udGVjaC13b3Jrcy1lbGRlcmx5LTY1LTg1L9IBXmh0dHBzOi8vYmdyLmNvbS8yMDIwLzA4LzIxL2Nvcm9uYXZpcnVzLXZhY2NpbmUtdXBkYXRlLXBmaXplci1iaW9udGVjaC13b3Jrcy1lbGRlcmx5LTY1LTg1L2FtcC8?oc=5", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-21T15:32:00+00:00", "summary": "In a significant coronavirus vaccine update, Pfizer and BioNTech announced additional details about their experimental drug that has just started Phase 2/3 testing.", "author": {"name": "Google News", "url": "http://news.google.co.uk/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/029/normal/image.png?1369860372"}}, {"title": "COVID-19 just schooled a bunch of universities", "url": "http://ct.moreover.com/?a=42898806161&p=1pl&v=1&x=Ce1jumLK8YKbMTMXsEissg", "license": "public", "citation_ids": [88265535, 88564054, 84060181], "posted_on": "2020-08-22T14:00:00+00:00", "summary": "Colleges got a schooling in virology this week. After ignoring recommendations from the local health department to hold virtual classes this fall, the University of North Carolina at Chapel Hill started classes on August 10, in person.", "author": {"name": "The Verge", "url": "http://www.theverge.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/042/normal/the_verge.png?1369846933"}}, {"title": "COVID-19 acabou de estudar em v\u00e1rias universidades", "url": "http://ct.moreover.com/?a=42898851684&p=1pl&v=1&x=U5a8iJ7zDqLUM708lp-9BQ", "license": "public", "citation_ids": [88265535, 88564054, 84060181], "posted_on": "2020-08-22T14:16:55+00:00", "summary": "As faculdades estudaram virologia esta semana. Depois de ignorar recomenda\u00e7\u00f5es do departamento de sa\u00fade local para dar aulas virtuais neste outono, a Universidade da Carolina do Norte em Chapel Hill come\u00e7ou as aulas em 10 de agosto, pessoalmente.", "author": {"name": "Replic\u00e1rio", "url": "https://replicario.com.br/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/276/normal/Capture_rpl.JPG?1574071393"}}, {"title": "COVID-19 just schooled a bunch of universities", "url": "http://ct.moreover.com/?a=42899228368&p=1pl&v=1&x=oikZkXquBqfka6S5E3hhQg", "license": "public", "citation_ids": [88265535, 88564054, 84060181], "posted_on": "2020-08-22T15:13:47+00:00", "summary": "Colleges got a schooling in virology this week. After ignoring recommendations from the local health department to hold virtual classes this fall, the University of North Carolina at Chapel Hill started classes on August 10, in person.", "author": {"name": "True Viral News", "url": "http://trueviralnews.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/725/normal/Screen_Shot_2017-07-31_at_15.00.40.png?1501509656"}}, {"title": "Pfizer/BioNTech COVID-19 vaccine candidate BNT162b2 profiled for large scale clinical trials", "url": "http://ct.moreover.com/?a=42907635357&p=1pl&v=1&x=IoeTHaXPz7K7sOXG5Ik89w", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-24T00:53:58+00:00", "summary": "Although two RNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates elicited similar, dose-dependent neutralizing antibody titers in both younger and older adults, a recent study by researchers from the U.S.", "author": {"name": "The Medical News", "url": "http://www.news-medical.net/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/146/normal/image.png?1369927508"}}, {"title": "Moderna's COVID-19 vaccine may work better in the elderly than competitors\u2019", "url": "https://www.biocentury.com/article/629786/moderna-s-covid-19-vaccine-may-work-better-in-the-elderly-than-competitors", "license": "public", "citation_ids": [86139672, 88564054], "posted_on": "2020-08-27T02:05:21+00:00", "summary": "Product Development Immunogenicity from Moderna\u2019s COVID-19 vaccine sustained in older adults Moderna\u2019s Phase I COVID-19 vaccine readout shows induction of antibody, T cell responses in elderly volunteers as robust as in younger adults, suggesting\u2026", "author": {"name": "BioCentury", "url": "http://www.biocentury.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/410/normal/Screen_Shot_2015-12-10_at_14.50.19.png?1449759038"}}, {"title": "mRNA Vaccine Candidate BNT162b2 Shows Promise; Recommended for Large-Scale Trials", "url": "https://www.trialsitenews.com/mrna-vaccine-candidate-bnt162b2-shows-promise-recommended-for-large-scale-trials/", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-28T01:37:49+00:00", "summary": "A recent study by researchers in the US and Germany of two mRNA-based COVID-19 vaccine candidates found that while they both lead to neutralizing antibodies, the candidate BNT162b2 was associated with less reactogenicity in older folks, \u201csupporting\u2026", "author": {"name": "TrialSite News", "url": "https://www.trialsitenews.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/110/normal/Screenshot_2019-07-12_at_12.25.34.png?1562930787"}}, {"title": "In September, 3 vaccines move into final stage of testing in the US", "url": "http://ct.moreover.com/?a=42976093167&p=1pl&v=1&x=aYyv105y70UbLKqdrlzroQ", "license": "public", "citation_ids": [86139797, 21583282, 88564054], "posted_on": "2020-09-01T19:17:01+00:00", "summary": "As hundreds gathered to protest vaccines in the United States and the United Kingdom over the weekend, AstraZeneca prepared to make a very big vaccine-related announcement.", "author": {"name": "Inverse", "url": "https://www.inverse.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/359/normal/Screen_Shot_2016-03-22_at_15.24.22.png?1458660294"}}, {"title": "A closer look at the vaccines Canada is betting on to stem the spread of COVID-19", "url": "http://ct.moreover.com/?a=42980120332&p=1pl&v=1&x=5zJBv_czMon5bhLMNzBbwQ", "license": "public", "citation_ids": [86787224, 87787092, 88564054], "posted_on": "2020-09-02T08:15:11+00:00", "summary": "Canada has announced that it has signed deals with four U.S. companies to reserve millions of doses of COVID-19 vaccines under development in an effort to make sure Canadians are at \u201cthe front of the line\u201d when a vaccine becomes available.", "author": {"name": "Express Informer", "url": "https://expressinformer.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/005/359/normal/Capture1.JPG?1578464781"}}, {"title": "A closer look at the vaccines Canada is betting on to stem the spread of COVID-19", "url": "http://ct.moreover.com/?a=42981202155&p=1pl&v=1&x=1-ZOLBEBERFAFWIn9Xc2xw", "license": "public", "citation_ids": [86787224, 87787092, 88564054], "posted_on": "2020-09-02T11:01:37+00:00", "summary": "Canada has announced that it has signed deals with four U.S. companies to reserve millions of doses of COVID-19 vaccines under development in an effort to make sure Canadians are at \"the front of the line\" when a vaccine becomes available.", "author": {"name": "MSN", "url": "http://www.msn.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/360/normal/Screen_Shot_2016-01-06_at_15.14.19.png?1452093279"}}, {"title": "Canada has made bets on these 4 COVID-19 vaccines. Here's a closer look.", "url": "http://ct.moreover.com/?a=42981388014&p=1pl&v=1&x=e--Vbs80K5_vLdsr_KzEDg", "license": "public", "citation_ids": [86787224, 87787092, 88564054], "posted_on": "2020-09-02T08:00:00+00:00", "summary": "Canada has announced that it has signed deals with four U.S. companies to reserve millions of doses of COVID-19 vaccines under development in an effort to make sure Canadians are at \"the front of the line\" when a vaccine becomes available.", "author": {"name": "CBC", "url": "http://www.cbc.ca/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/014/normal/cbc.png?1369846905"}}, {"title": "Which Coronavirus Vaccine Candidates Are The Furthest Along?", "url": "http://ct.moreover.com/?a=43005799253&p=1pl&v=1&x=y2m6K8ZADs4fFXto1CaHxA", "license": "public", "citation_ids": [88564054, 89071069], "posted_on": "2020-09-05T11:40:18+00:00", "summary": "Despite recent rumblings from the Trump administration, it remains unlikely that a vaccine for COVID-19 will be approved by the end of the year.", "author": {"name": "International Business Times", "url": "http://www.ibtimes.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/059/normal/international_business_times.png?1369846945"}}, {"title": "Generex Biotechnology's COVID-19 Vaccine Could Outperform Competition", "url": "http://ct.moreover.com/?a=43027698079&p=1pl&v=1&x=UXf6WmmhgsvVil5yJ9urzA", "license": "public", "citation_ids": [86686099, 86139797, 88564054, 80207209, 60607868, 84479505, 84064040, 6628922, 58330282, 80427149, 63724417], "posted_on": "2020-09-08T15:31:44+00:00", "summary": "Summary Generex Biotechnology's COVID-19 vaccine is potentially superior to leading competition.", "author": {"name": "Seeking Alpha", "url": "http://seekingalpha.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/665/normal/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336"}}, {"title": "There are seven coronavirus vaccine candidates being tested in the U.S. \u2014 here's where they stand", "url": "http://ct.moreover.com/?a=43028418048&p=1pl&v=1&x=Qn5oCX5MAybgF5wFuESh_A", "license": "public", "citation_ids": [85041504, 88564054, 80996494, 76647820, 85794306, 82934700, 85760934, 79275349, 84323084, 80903960, 89352278], "posted_on": "2020-09-08T17:19:00+00:00", "summary": "By Jaimy Lee At least three of the still investigational vaccines have moved into Phase 3 clinical trials The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history.", "author": {"name": "Morning Star", "url": "https://www.morningstar.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/912/normal/Screen_Shot_2018-09-17_at_18.20.59.png?1537204915"}}, {"title": "\u0412\u0430\u043a\u0446\u0438\u043d\u0430 \u043e\u0442 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u0430: \u0434\u0435\u0432\u044f\u0442\u044c \u043b\u0438\u0434\u0435\u0440\u043e\u0432-\u0440\u0430\u0437\u0440\u0430\u0431\u043e\u0442\u043e\u043a", "url": "http://ct.moreover.com/?a=43043940439&p=1pl&v=1&x=m_uHfhVDByOBL06ke29y3Q", "license": "public", "citation_ids": [31575510, 88564054, 17598734, 86139672, 88937640, 88202546], "posted_on": "2020-09-10T00:00:00+00:00", "summary": "\u0413\u0440\u0443\u043f\u043f\u0430 \u0438\u0442\u0430\u043b\u044c\u044f\u043d\u0441\u043a\u0438\u0445 \u0443\u0447\u0435\u043d\u044b\u0445 \u0438\u0437 \u043d\u0435\u0441\u043a\u043e\u043b\u044c\u043a\u0438\u0445 \u043d\u0430\u0443\u0447\u043d\u044b\u0445 \u0446\u0435\u043d\u0442\u0440\u043e\u0432 \u043e\u0431\u043d\u0430\u0440\u0443\u0436\u0438\u043b\u0430 \u0441\u0442\u0430\u0442\u0438\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0430\u043d\u043e\u043c\u0430\u043b\u0438\u0438 \u0432 \u0441\u0442\u0430\u0442\u044c\u0435 \u043e \u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0432\u0430\u043a\u0446\u0438\u043d\u0435 \u043e\u0442 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u0430 \u00ab\u0421\u043f\u0443\u0442\u043d\u0438\u043a V\u00bb \u0438 9 \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044f \u043e\u043f\u0443\u0431\u043b\u0438\u043a\u043e\u0432\u0430\u043b\u0430 \u043e\u0442\u043a\u0440\u044b\u0442\u043e\u0435 \u043f\u0438\u0441\u044c\u043c\u043e \u0440\u0435\u0434\u0430\u043a\u0442\u043e\u0440\u0430\u043c \u043d\u0430\u0443\u0447\u043d\u043e\u0433\u043e \u0436\u0443\u0440\u043d\u0430\u043b\u0430 The Lancet, \u0433\u0434\u0435 \u0432\u044b\u0448\u043b\u0430 \u043f\u0443\u0431\u043b\u0438\u043a\u0430\u0446\u0438\u044f\u2026", "author": {"name": "Polit", "url": "http://www.polit.ru", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/888/normal/Screen_Shot_2016-01-27_at_13.59.12.png?1453903239"}}, {"title": "[ BINTAI ] COVID Vaccine with Generex Could Outperform Competition", "url": "http://ct.moreover.com/?a=43076729628&p=1pl&v=1&x=4LYxDUmfn8gHtaoRaWlnSw", "license": "public", "citation_ids": [86686099, 86139797, 88564054, 80207209, 60607868, 84479505, 84064040, 6628922, 58330282, 80427149, 63724417], "posted_on": "2020-09-15T01:58:19+00:00", "summary": "The below Analyst Report is Exactly the reason why BINTAI is surging today, and will continue to surge https://seekingalpha.com/article/4373034-generex-biotechnologys-covidminus-19-vaccine-outperform-competition Generex Biotechnology's COVID-19\u2026", "author": {"name": "I3investor", "url": "https://klse.i3investor.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/416/normal/Capture16.PNG?1575018920"}}, {"title": "Coronavirus Vaccine Trials Could Suffer From Shortcuts", "url": "http://ct.moreover.com/?a=43137292108&p=1pl&v=1&x=EjxDvGwe7icT1-v-dGSwuA", "license": "public", "citation_ids": [101837767, 88564054], "posted_on": "2020-09-22T17:05:44+00:00", "summary": "We may not find out whether the vaccines prevent moderate or severe cases of Covid-19.", "author": {"name": "New York Times", "url": "http://www.nytimes.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/022/normal/image.png?1369859672"}}, {"title": "A coronavirus vaccine may only work for one year. Here\u2019s what that means for society", "url": "http://ct.moreover.com/?a=43148009056&p=1pl&v=1&x=ae5pkcI9VVVsU8zXcJG3JQ", "license": "public", "citation_ids": [90053302, 88564054, 85794306, 86123198, 80724589], "posted_on": "2020-09-23T22:09:01+00:00", "summary": "It's a conundrum for vaccine researchers and producers alike: what's the best strategy for vaccinating against a deadly virus if the immune system will forget how to protect itself against ita year later? Recent research that suggests that novel\u2026", "author": {"name": "Salon", "url": "http://salon.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/290/normal/Screen_Shot_2016-01-06_at_15.18.42.png?1452093542"}}, {"title": "Coronavirus vaccine trial participants report exhaustion, fever and headaches \u2014 but worth it", "url": "http://ct.moreover.com/?a=43209082910&p=1pl&v=1&x=5SholR2RpTgEUrHf934zEw", "license": "public", "citation_ids": [88564054, 85794306], "posted_on": "2020-10-01T11:00:00+00:00", "summary": "High fever, body aches, headaches and exhaustion are some of the symptoms participants in Moderna and Pfizer's coronavirus vaccine trials say they felt after receiving the shots.", "author": {"name": "CNBC", "url": "http://www.cnbc.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/411/normal/Screen_Shot_2016-01-12_at_14.43.08.png?1452609805"}}, {"title": "Meet the People We're Counting on for a Covid-19 Vaccine", "url": "http://ct.moreover.com/?a=43209936889&p=1pl&v=1&x=3fJHWO2-au5QYKRz1OGDAw", "license": "public", "citation_ids": [80996494, 83022394, 80996494, 11116470, 88564054, 88111868], "posted_on": "2020-09-30T17:01:21+00:00", "summary": "This spring, doing rounds in the Covid-19 units at the University of Maryland School of Medicine hospital in Baltimore, Dr.", "author": {"name": "Rolling Stone", "url": "http://www.rollingstone.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/815/normal/Screen_Shot_2016-01-27_at_10.19.56.png?1453890068"}}, {"title": "Meet the People We\u2019re Counting on for a Covid-19 Vaccine", "url": "http://ct.moreover.com/?a=43211246712&p=1pl&v=1&x=XgcaUOA6GKIlGfKe2kACgg", "license": "public", "citation_ids": [80996494, 83022394, 80996494, 11116470, 88564054, 88111868], "posted_on": "2020-10-01T13:00:21+00:00", "summary": "This spring, doing rounds in the Covid-19 units at the University of Maryland School of Medicine hospital in Baltimore, Dr.", "author": {"name": "Yahoo!", "url": "http://www.yahoo.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/726/normal/Screen_Shot_2016-01-26_at_15.40.46.png?1453822868"}}, {"title": "Coronavirus Vaccine Trial Participants Report Day-Long Exhaustion, Fever and Headaches \u2014 But Say It's Worth It", "url": "http://ct.moreover.com/?a=43211953143&p=1pl&v=1&x=05PBNRpQykCASgFINQ25ZQ", "license": "public", "citation_ids": [88564054, 85794306], "posted_on": "2020-10-01T10:21:38+00:00", "summary": "Luke Hutchison woke up in the middle of the night with chills and a fever after taking the COVID-19 booster shot in Moderna\u2019s vaccine trial.", "author": {"name": "NBC4", "url": "http://www.nbclosangeles.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/515/normal/Screen_Shot_2016-01-06_at_15.43.15.png?1452095011"}}, {"title": "Coronavirus Vaccine Trial Participants Report Day-Long Exhaustion, Fever and Headaches \u2014 But Say It's Worth It", "url": "http://ct.moreover.com/?a=43211968641&p=1pl&v=1&x=XhchWu-4qffDO3zRU3dlrA", "license": "public", "citation_ids": [88564054, 85794306], "posted_on": "2020-10-01T13:21:38+00:00", "summary": "Luke Hutchison woke up in the middle of the night with chills and a fever after taking the COVID-19 booster shot in Moderna\u2019s vaccine trial.", "author": {"name": "NBC Miami", "url": "https://www.nbcmiami.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/917/normal/NBC_OTS_MIAMI.png?1572002512"}}, {"title": "Participants in Coronavirus Vaccine Trials Report Fever, Exhaustion", "url": "http://ct.moreover.com/?a=43212632370&p=1pl&v=1&x=0HtOYyQxZHlu9IPiPlzKCQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-10-01T15:28:45+00:00", "summary": "The participants taking part in phase 3 clinical trials for the Moderna and Pfizer vaccine candidates are reporting troublesome side effects such as fever, headaches, and exhaustion after receiving the drugs.", "author": {"name": "newsmax.com", "url": "http://www.newsmax.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/354/normal/Screen_Shot_2015-04-07_at_17.01.46.png?1428422529"}}, {"title": "Compromiso hist\u00f3rico para la producci\u00f3n de vacunas seguras frente a la COVID-19", "url": "http://ct.moreover.com/?a=43234617204&p=1pl&v=1&x=0rzbM3ZUwaoDr8sT0GalJA", "license": "public", "citation_ids": [88010441, 76647820, 88564054, 84323084, 43562754], "posted_on": "2020-10-04T19:16:14+00:00", "summary": "Es m\u00e1s f\u00e1cil resolver pronto un problema si nos ponemos a buscar a la vez muchas soluciones distintas.", "author": {"name": "The Conversation", "url": "http://theconversation.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/071/normal/the_conversation.png?1369846953"}}, {"title": "Compromiso hist\u00f3rico para la producci\u00f3n de vacunas seguras frente a la COVID-19", "url": "http://ct.moreover.com/?a=43239548721&p=1pl&v=1&x=EPkNh02nmLFCKFY3nEy-Lg", "license": "public", "citation_ids": [84323084, 43562754, 88010441, 76647820, 88564054], "posted_on": "2020-10-05T12:06:49+00:00", "summary": "Es m\u00e1s f\u00e1cil resolver pronto un problema si nos ponemos a buscar a la vez muchas soluciones distintas.", "author": {"name": "RED/ACCI\u00d3N", "url": "https://www.redaccion.com.ar/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/909/normal/Capture5.PNG?1576749269"}}, {"title": "Coronavirus update: J&J vaccine trial hits pause as US doubles down on antibody therapies", "url": "http://ct.moreover.com/?a=43304496424&p=1pl&v=1&x=8m-ZugVeRLN1VPp1FHZInA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-10-13T15:35:38+00:00", "summary": "Johnson & Johnson (JNJ) announced late Monday it was pausing shots in its late-stage coronavirus vaccine trial due to an adverse event, but plans to continue enrolling patients and stick to the current manufacturing timeline.", "author": {"name": "Yahoo! Finance Canada ", "url": "https://ca.finance.yahoo.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/217/normal/Screen_Shot_2014-10-13_at_15.22.14.png?1413210203"}}, {"title": "Coronavirus update: J&J vaccine trial hits pause as US doubles down on antibody therapies", "url": "http://ct.moreover.com/?a=43304513438&p=1pl&v=1&x=eCG2WPg_4UhAkCGVBew5jg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-10-13T15:42:48+00:00", "summary": "Johnson & Johnson () announced late Monday it was pausing shots in its late-stage coronavirus vaccine trial due to an adverse event, but plans to continue enrolling patients and stick to the current manufacturing timeline.", "author": {"name": "Yahoo! Finance USA", "url": "http://finance.yahoo.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/620/normal/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}}, {"title": "Coronavirus update: J&J vaccine trial hits pause as US doubles down on antibody therapies", "url": "http://ct.moreover.com/?a=43304554199&p=1pl&v=1&x=WkSH-ydDCLHAhgXayJNLkw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-10-13T15:35:38+00:00", "summary": "Johnson & Johnson (JNJ) announced late Monday it was pausing shots in its late-stage coronavirus vaccine trial due to an adverse event, but plans to continue enrolling patients and stick to the current manufacturing timeline.", "author": {"name": "Yahoo! Finance USA", "url": "http://finance.yahoo.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/620/normal/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}}, {"title": "Coronavirus update: J&J and Eli Lilly trials hit pause as US doubles down on antibody therapies", "url": "http://ct.moreover.com/?a=43321034026&p=1pl&v=1&x=flk43uRGfdk-iw1PAqmwRQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-10-13T15:35:38+00:00", "summary": "Johnson & Johnson ( JNJ ) announced late Monday it was pausing shots in its late-stage coronavirus vaccine trial due to an adverse event, but plans to continue enrolling patients and stick to the current manufacturing timeline.", "author": {"name": "Yahoo! Finance USA", "url": "http://finance.yahoo.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/620/normal/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}}, {"title": "Como um \"elixir da juventude\" pode salvar idosos da Covid-19", "url": "http://ct.moreover.com/?a=43325851016&p=1pl&v=1&x=ZEgROp117CnaZ0kY69wrvg", "license": "public", "citation_ids": [92374259, 88564054, 91353040, 44891765, 94069242], "posted_on": "2020-10-16T00:00:00+00:00", "summary": "O novo coronav\u00edrus \u00e9 particularmente perigoso nos mais adultos e a vacina pode n\u00e3o \u00e9 t\u00e3o eficaz devido ao fraco sistema imunit\u00e1rio.", "author": {"name": "Sabado Portugal", "url": "https://www.sabado.pt", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/623/normal/Screenshot_2019-10-14_at_15.45.55.png?1571064411"}}, {"title": "Here\u2019s how soon we may start seeing COVID-19 vaccines roll out", "url": "http://ct.moreover.com/?a=43366397791&p=1pl&v=1&x=nUcK8RRwmm_ocAm1oN_ZlQ", "license": "public", "citation_ids": [88564054, 85794306, 91214423, 86139797], "posted_on": "2020-10-21T15:27:45+00:00", "summary": "Health care workers will be the first people in Michigan to get a coronavirus vaccine, according to an interim priority plan state health officials released Tuesday evening for when a COVID-19 vaccine is green-lighted in the U.S.", "author": {"name": "Detroit Free Press", "url": "http://www.freep.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/409/normal/Screen_Shot_2016-01-13_at_11.58.21.png?1452686322"}}, {"title": "Pfizer\u2019s vaccine is more than 90 percent effective in first analysis, company reports", "url": "http://ct.moreover.com/?a=43515011612&p=1pl&v=1&x=BAI7lsDxlAeyJJ5JO1PvCg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-09T11:45:11+00:00", "summary": "A front-runner coronavirus vaccine developed by drug giant Pfizer and German biotechnology firm BioNTech was more than 90 percent effective at protecting people compared with a placebo saline shot, according to an interim analysis by an independent\u2026", "author": {"name": "Washington Post", "url": "http://www.washingtonpost.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/001/normal/washington_post.png?1369846885"}}, {"title": "Report: Pfizer\u2019s vaccine more than 90% effective", "url": "http://ct.moreover.com/?a=43515143714&p=1pl&v=1&x=AoC60L6SIhwjX63dQWVJCQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-09T12:34:46+00:00", "summary": "A front-runner coronavirus vaccine developed by drug giant Pfizer and German biotechnology firm BioNTech was more than 90 percent effective at protecting people compared with a placebo saline shot, according to an interim analysis by an independent\u2026", "author": {"name": "MSN", "url": "http://www.msn.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/360/normal/Screen_Shot_2016-01-06_at_15.14.19.png?1452093279"}}, {"title": "According to company reports, Pfizer\u2019s coronavirus vaccine is more than 90 percent effective in initial analysis", "url": "http://ct.moreover.com/?a=43515163596&p=1pl&v=1&x=qhMqU2PPyHA0Q0uBmw0D1Q", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-09T12:37:21+00:00", "summary": "\u201cI would say it\u2019s a historic moment. Nothing like this has ever happened before.", "author": {"name": "NewsBeezer", "url": "https://newsbeezer.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/466/normal/19.PNG?1569478757"}}, {"title": "Pfizer \u0437\u0430\u044f\u0432\u0438\u043b\u0430 \u043e 90% \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u0438 \u0441\u0432\u043e\u0435\u0439 \u0432\u0430\u043a\u0446\u0438\u043d\u044b \u043e\u0442 COVID-19", "url": "http://ct.moreover.com/?a=43516038260&p=1pl&v=1&x=N0AAPAbIi-dMoJojpkc2Pw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-09T00:00:00+00:00", "summary": "\u0410\u043c\u0435\u0440\u0438\u043a\u0430\u043d\u0441\u043a\u0430\u044f \u0444\u0430\u0440\u043c\u043a\u043e\u043c\u043f\u0430\u043d\u0438\u044f Pfizer \u043e\u0442\u0447\u0438\u0442\u0430\u043b\u0430\u0441\u044c \u043e \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u0430\u0445 \u0442\u0440\u0435\u0442\u044c\u0435\u0439 \u0444\u0430\u0437\u044b \u0438\u0441\u043f\u044b\u0442\u0430\u043d\u0438\u0439 \u0432\u0430\u043a\u0446\u0438\u043d\u044b \u043e\u0442 \u043a\u043e\u0432\u0438\u0434 BNT162b2.", "author": {"name": "Polit", "url": "http://www.polit.ru", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/888/normal/Screen_Shot_2016-01-27_at_13.59.12.png?1453903239"}}, {"title": "Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study", "url": "http://ct.moreover.com/?a=43516558966&p=1pl&v=1&x=Ewla8UetaEKTAck5pjNKpQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-09T16:03:34+00:00", "summary": "(Bloomberg) -- A vaccine developed by Pfizer Inc. and BioNTech SE protects most people from Covid-19, according to a study whose early findings sent stock prices surging and were hailed by the top U.S.", "author": {"name": "Yahoo! Finance USA", "url": "http://finance.yahoo.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/620/normal/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}}, {"title": "Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study", "url": "http://ct.moreover.com/?a=43517211021&p=1pl&v=1&x=SJ7ZQs5Hxt54E03movkQug", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-09T17:44:20+00:00", "summary": "(Bloomberg) -- A vaccine developed by Pfizer Inc. and BioNTech SE protects most people from Covid-19, according to a study whose early findings sent stock prices surging and were hailed by the top U.S.", "author": {"name": "MSN", "url": "http://www.msn.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/360/normal/Screen_Shot_2016-01-06_at_15.14.19.png?1452093279"}}, {"title": "Pfizer's COVID-19 Vaccine 90 Percent Effective: Initial Data", "url": "http://ct.moreover.com/?a=43519326846&p=1pl&v=1&x=eCnoarlpH1UWnTVk3sXKUA", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-09T21:44:24+00:00", "summary": "P reliminary data from pharmaceutical giant Pfizer and German biotechnology firm BioNTech show that their COVID-19 vaccine is more than 90 percent effective at protecting people from the infection, compared to patients who received a placebo saline\u2026", "author": {"name": "The Scientist Magazine", "url": "http://www.the-scientist.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/096/normal/image.png?1369860108"}}, {"title": "Foreldrene kom til landet som gjestearbeidere. N\u00e5 st\u00e5r ekteparet bak vaksinen som vekker h\u00e5p i hele verden.", "url": "http://ct.moreover.com/?a=43522649721&p=1pl&v=1&x=cLFTGNmQewnrZL_F8_6JxQ", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-10T10:14:59+00:00", "summary": "De er barn av tyrkiske immigranter. N\u00e5 st\u00e5r de bak vaksinen som vekker h\u00e5p i hele verden.", "author": {"name": "Aftenposten", "url": "http://www.aftenposten.no/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/619/normal/Screen_Shot_2016-01-12_at_14.11.03.png?1452607877"}}, {"title": "Coronavirus - RNA-Impfstoffe und der Wirkstoff BNT162b2", "url": "http://ct.moreover.com/?a=43523244123&p=1pl&v=1&x=7jtlKPRwKCvdg5vHoRVlXw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-11-10T11:54:55+00:00", "summary": "Das Mainzer Unternehmen Biontech und der US-Pharmakonzern Pfizer lie\u00dfen mit ihrem Impfstoff-Kandidaten BNT162b2 aufhorchen, bietet er doch einer Aussendung der Firmen zufolge einen mehr als 90-prozentigen Schutz vor der Krankheit Covid-19.", "author": {"name": "APA", "url": "http://science.apa.at/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/889/normal/Screen_Shot_2016-01-27_at_14.02.58.png?1453903448"}}, {"title": "\u0644\u0642\u0627\u062d \"\u0641\u0627\u064a\u0632\u0631- \u0628\u064a\u0648\u0646\u062a\u0643\".. \u0644\u0645\u0627\u0630\u0627 \u0633\u064a\u0633\u062a\u0645\u0631 \"\u0643\u0648\u0641\u064a\u062f\u0661\u0669\" \u062d\u062a\u0649 \u0662\u0660\u0662\u0662\u061f", "url": "http://ct.moreover.com/?a=43538844566&p=1pl&v=1&x=zT347TCS-FC6o4D1zOYfrw", "license": "public", "citation_ids": [12309091, 88564054, 93968868, 85834073], "posted_on": "2020-11-12T06:11:08+00:00", "summary": "\u0623\u0635\u062f\u0631\u062a \u0627\u0644\u0634\u0631\u0643\u062a\u0627\u0646 \"\u0641\u0627\u064a\u0632\u0631-\u0628\u0627\u064a\u0648\u0646\u062a\u0643\" \u0625\u0639\u0644\u0627\u0646\u0627 \u0642\u0628\u0644 \u0623\u064a\u0627\u0645\u060c \u0623\u0646 \u062a\u062d\u0644\u064a\u0644\u0627 \u0645\u0628\u0643\u0631\u0627 \u0642\u062f \u0623\u0641\u0627\u062f \u0628\u0641\u0627\u0639\u0644\u064a\u0629 \u0642\u062f\u0631\u0647\u0627 90% \u0644\u0644\u0642\u0627\u062d \u0627\u0644\u062c\u062f\u064a\u062f \"BNT162b2\" \u0648\u064a\u064f\u062c\u0631\u0651\u0650\u0628\u0647 \u0623\u0643\u062b\u0631 \u0645\u0646 43 \u0623\u0644\u0641 \u0634\u062e\u0635 \u062d\u0648\u0644 \u0627\u0644\u0639\u0627\u0644\u0645.", "author": {"name": "Aljazeera", "url": "https://www.aljazeera.net/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/005/444/normal/Screenshot_2020-05-13_at_09.48.38.png?1589359847"}}, {"title": "Why we should prioritise older people when we get a COVID vaccine", "url": "http://ct.moreover.com/?a=43564873401&p=1pl&v=1&x=D34kLxQq3Hw5k8aM6ADZOA", "license": "public", "citation_ids": [94321301, 90492930, 3384575, 77666763, 93993411, 30454908, 935781, 88564054, 50259249, 89759729, 3954812, 90094590, 88378496], "posted_on": "2020-11-15T18:53:01+00:00", "summary": "Several COVID-19 vaccines are in late-stage clinical trials. So discussion is turning to who should receive these vaccines first, should they be approved for use.", "author": {"name": "The Conversation", "url": "http://theconversation.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/071/normal/the_conversation.png?1369846953"}}, {"title": "MIL-Evening Report: Why we should prioritise older people when we get a COVID vaccine", "url": "http://ct.moreover.com/?a=43564906787&p=1pl&v=1&x=8bJgwcEKR_kbmjqlHQvrIA", "license": "public", "citation_ids": [94321301, 90492930, 3384575, 77666763, 93993411, 30454908, 935781, 88564054, 50259249, 89759729, 3954812, 90094590, 88378496], "posted_on": "2020-11-15T19:19:20+00:00", "summary": "\u2013 By Kylie Quinn, Vice-Chancellor\u2019s Research Fellow, School of Health and Biomedical Sciences, RMIT University Several COVID-19 vaccines are in late-stage clinical trials.", "author": {"name": "Foreign Affairs New Zealand", "url": "http://foreignaffairs.co.nz/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/827/normal/Screen_Shot_2016-01-27_at_10.47.41.png?1453891760"}}, {"title": "News story from Big News Network on Sunday 15 November 2020", "url": null, "license": "nla", "citation_ids": [94321301, 90492930, 3384575, 77666763, 93993411, 30454908, 935781, 88564054, 50259249, 89759729, 3954812, 90094590, 88378496], "posted_on": "2020-11-15T20:38:27+00:00", "summary": null, "author": {"name": "Big News Network", "url": "http://www.bignewsnetwork.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/944/normal/Screen_Shot_2016-01-12_at_14.32.33.png?1452609170"}}, {"title": "We should vaccinate older people first", "url": "http://ct.moreover.com/?a=43567334567&p=1pl&v=1&x=g7-n1QRuJ-aaOxjl3BKEzg", "license": "public", "citation_ids": [94321301, 90492930, 3384575, 77666763, 93993411, 30454908, 935781, 88564054, 50259249, 89759729, 3954812, 90094590, 88378496, 94321306], "posted_on": "2020-11-15T13:00:00+00:00", "summary": "Kylie Quinn, RMIT University Several COVID-19 vaccines are in late-stage clinical trials.", "author": {"name": "Your Life Choices", "url": "https://www.yourlifechoices.com.au/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/913/normal/Capture8.PNG?1576753558"}}, {"title": "Why we should prioritise older people when we get a COVID vaccine", "url": "http://ct.moreover.com/?a=43570785526&p=1pl&v=1&x=f_zn36-jqkslRZaCLMCJVQ", "license": "public", "citation_ids": [90492930, 3384575, 30454908, 935781, 88564054, 50259249, 3954812, 90094590, 94321306, 94321301, 77666763, 93993411, 89759729, 88378496], "posted_on": "2020-11-16T14:37:29+00:00", "summary": "Older people are more likely to become severely unwell if they contract coronavirus.", "author": {"name": "MedicalXpress", "url": "http://medicalxpress.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/152/normal/image.png?1369925783"}}, {"title": "Pfizer and Moderna\u2019s \u201c95% Effective\u201d Vaccines\u2014Let\u2019s be Cautious and First See the Full Data - Global Research", "url": "http://ct.moreover.com/?a=43705388490&p=1pl&v=1&x=s-vUHIFMcym-yq3E1tpNQA", "license": "public", "citation_ids": [92838069, 92845144, 94797428, 88778764, 433003, 94968613, 1856127, 88564054, 91430619, 85794306, 92401921], "posted_on": "2020-12-03T14:20:07+00:00", "summary": "In the United States, all eyes are on Pfizer and Moderna. The topline efficacy results from their experimental covid-19 vaccine trials are astounding at first glance.", "author": {"name": "Globalresearch", "url": "http://www.globalresearch.ca/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/950/normal/Screen_Shot_2016-02-03_at_09.55.56.png?1454493377"}}, {"title": "Wie sich die CoV-Impfung anf\u00fchlt", "url": "https://science.orf.at/stories/3203416/", "license": "public", "citation_ids": [95589463, 88564054], "posted_on": "2020-12-07T16:58:55+00:00", "summary": "Nebenwirkungen RNA-Impfstoffe gegen Covid-19 k\u00f6nnen unangenehme Nebenwirkungen hervorrufen.", "author": {"name": "ORF.at", "url": "http://orf.at/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/408/normal/Screen_Shot_2016-02-02_at_11.32.53.png?1454412786"}}, {"title": "The FDA says Pfizer's Covid vaccine is safe and effective. But brace yourself for the second shot, trial participants warn", "url": "http://ct.moreover.com/?a=43745204262&p=1pl&v=1&x=VluPSGQVD1ao7WlIh3OWIA", "license": "public", "citation_ids": [88564054, 85794306], "posted_on": "2020-12-08T19:31:06+00:00", "summary": "The FDA said data from Pfizer's Covid vaccine trials show that side effects are common, though there are \u201cno specific safety concerns identified that would preclude issuance of an\u201d emergency use authorization.", "author": {"name": "CNBC", "url": "http://www.cnbc.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/411/normal/Screen_Shot_2016-01-12_at_14.43.08.png?1452609805"}}, {"title": "The FDA says Pfizer\u2019s Covid vaccine is safe and effective. But trial participants warn of intense symptoms after second shot", "url": "http://ct.moreover.com/?a=43745970776&p=1pl&v=1&x=xMuFxc83SxJxEOttj-RRmQ", "license": "public", "citation_ids": [88564054, 85794306], "posted_on": "2020-12-08T23:09:47+00:00", "summary": "#left div.single div.thumb-gAd.gad-bottom-respon{width: 616px;} @media(max-width: 980px){ #left div.single div.content-gAd-bottom.mobile-noimg{width: 336px; height: 280px;} } @media(max-width: 340px){ #left div.single div.content-gAd-bottom.mobile\u2026", "author": {"name": "Pressfrom", "url": "https://pressfrom.info", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/169/normal/Screenshot_2019-08-08_at_15.06.30.png?1565273214"}}, {"title": "Coronavirus vaccine trial participant reports violent chills, fatigue, and muscle pain", "url": "http://ct.moreover.com/?a=43746940967&p=1pl&v=1&x=0p6hkENUo141tidVTPwh1Q", "license": "public", "citation_ids": [88564054, 85794306], "posted_on": "2020-12-09T02:33:59+00:00", "summary": "The Pfizer-BioNTech coronavirus vaccine is both safe and effective, according to the U.S.", "author": {"name": "The Standard", "url": "http://www.thestandard.com.hk/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/861/normal/Screen_Shot_2018-07-12_at_11.29.03.png?1531391438"}}, {"title": "Corona-Impfung: Deshalb sind die Nebenwirkungen gut", "url": "http://ct.moreover.com/?a=43760361391&p=1pl&v=1&x=NpB8A_DALfZnLwsXEw7Rnw", "license": "public", "citation_ids": [88564054], "posted_on": "2020-12-10T16:31:56+00:00", "summary": "Eine Impfung gegen das Coronavirus ist h\u00e4ufig mit (kurzfristigen) Nebenwirkungen verbunden.", "author": {"name": "Heute", "url": "http://www.heute.at/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/629/normal/image.png?1395749218"}}, {"title": "\u0410\u043c\u0435\u0440\u0438\u043a\u0430\u043d\u0441\u043a\u0438\u0439 \u0440\u0435\u0433\u0443\u043b\u044f\u0442\u043e\u0440 \u043e\u0434\u043e\u0431\u0440\u0438\u043b \u0434\u043b\u044f \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043d\u0438\u044f \u0432\u0430\u043a\u0446\u0438\u043d\u0443 Pfizer", "url": "http://ct.moreover.com/?a=43765050950&p=1pl&v=1&x=_xL9QtZmPTll8dxQspXz5Q", "license": "public", "citation_ids": [88564054], "posted_on": "2020-12-11T00:00:00+00:00", "summary": "\u042d\u043a\u0441\u043f\u0435\u0440\u0442\u044b \u0423\u043f\u0440\u0430\u0432\u043b\u0435\u043d\u0438\u044f \u043f\u043e \u043a\u043e\u043d\u0442\u0440\u043e\u043b\u044e \u0437\u0430 \u043f\u0440\u043e\u0434\u0443\u043a\u0442\u0430\u043c\u0438 \u043f\u0438\u0442\u0430\u043d\u0438\u044f \u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430\u043c\u0438 (FDA) \u0421\u0428\u0410 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u043e\u0432\u0430\u043b\u0438 \u043e\u0434\u043e\u0431\u0440\u0438\u0442\u044c \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043d\u0438\u0435 \u0432\u0430\u043a\u0446\u0438\u043d\u044b \u043e\u0442 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u043d\u043e\u0439 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438 BNT162b2, \u043a\u043e\u0442\u043e\u0440\u0443\u044e \u0440\u0430\u0437\u0440\u0430\u0431\u043e\u0442\u0430\u043b\u0430 \u0430\u043c\u0435\u0440\u0438\u043a\u0430\u043d\u0441\u043a\u0430\u044f \u0444\u0430\u0440\u043c\u043a\u043e\u043c\u043f\u0430\u043d\u0438\u044f Pfizer \u0441\u043e\u0432\u043c\u0435\u0441\u0442\u043d\u043e \u0441 \u043d\u0435\u043c\u0435\u0446\u043a\u043e\u0439 BioNTech, \u043f\u0438\u0448\u0435\u0442\u2026", "author": {"name": "Polit", "url": "http://www.polit.ru", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/888/normal/Screen_Shot_2016-01-27_at_13.59.12.png?1453903239"}}, {"title": "\u0421\u0428\u0410 \u043e\u0434\u043e\u0431\u0440\u0438\u043b\u0438 \u0430\u043d\u0442\u0438\u043a\u043e\u0432\u0438\u0434\u043d\u0443\u044e \u0432\u0430\u043a\u0446\u0438\u043d\u0443 Pfizer. \u0422\u0440\u0430\u043c\u043f \u0437\u0430\u044f\u0432\u0438\u043b, \u0447\u0442\u043e \u043c\u0430\u0441\u0441\u043e\u0432\u0430\u044f \u0432\u0430\u043a\u0446\u0438\u043d\u0430\u0446\u0438\u044f \u043d\u0430\u0447\u043d\u0435\u0442\u0441\u044f \u0432 \u0442\u0435\u0447\u0435\u043d\u0438\u0435 \u0441\u0443\u0442\u043e\u043a", "url": "http://ct.moreover.com/?a=43773216249&p=1pl&v=1&x=urF_ARiQnSw6q9Bhr3EOjg", "license": "public", "citation_ids": [88564054], "posted_on": "2020-12-12T00:00:00+00:00", "summary": "FDA \u0421\u0428\u0410 \u043e\u0434\u043e\u0431\u0440\u0438\u043b\u043e \u0430\u043d\u0442\u0438\u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u043d\u0443\u044e \u0432\u0430\u043a\u0446\u0438\u043d\u0443 Pfizer, \u0440\u0430\u0437\u0440\u0430\u0431\u043e\u0442\u0430\u043d\u043d\u0443\u044e \u0441\u043e\u0432\u043c\u0435\u0441\u0442\u043d\u043e \u0441 BioNTech.", "author": {"name": "Polit", "url": "http://www.polit.ru", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/888/normal/Screen_Shot_2016-01-27_at_13.59.12.png?1453903239"}}, {"title": "News story from Chicago Tribune on Tuesday 15 December 2020", "url": null, "license": "nla", "citation_ids": [94961701, 88564054], "posted_on": "2020-12-15T15:51:26+00:00", "summary": null, "author": {"name": "Chicago Tribune", "url": "http://www.chicagotribune.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/010/normal/chicago_tribune.png?1369846898"}}, {"title": "News story from Baltimore Sun on Tuesday 15 December 2020", "url": null, "license": "nla", "citation_ids": [94961701, 88564054], "posted_on": "2020-12-15T15:51:26+00:00", "summary": null, "author": {"name": "Baltimore Sun", "url": "http://www.baltimoresun.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/035/normal/image.jpeg?1369859253"}}, {"title": "No, COVID-19 vaccines don\u2019t contain Satan\u2019s microchips (and other scary conspiracy theories aren\u2019t true, either)", "url": "http://ct.moreover.com/?a=43797065516&p=1pl&v=1&x=c8osfwtDJWZfgI7bicV2TA", "license": "public", "citation_ids": [94961701, 88564054], "posted_on": "2020-12-15T17:16:08+00:00", "summary": "CHICAGO \u2014 If you want an idea of the conspiracy theories that hang over COVID-19 vaccines, there\u2019s no better summation than a 40-second TikTok video posted in October by a performer named Taylor Rousseau.", "author": {"name": "Lancaster Online", "url": "https://lancasteronline.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/408/normal/ooooooooooooo.PNG?1575014067"}}, {"title": "No, COVID-19 vaccines don\u2019t contain Satan\u2019s microchips (and other scary conspiracy theories aren\u2019t true, either)", "url": "http://ct.moreover.com/?a=43797151648&p=1pl&v=1&x=_2zmYoq-sTykFp1XzZvNIg", "license": "public", "citation_ids": [94961701, 88564054], "posted_on": "2020-12-15T17:16:08+00:00", "summary": "CHICAGO \u2014 If you want an idea of the conspiracy theories that hang over COVID-19 vaccines, there\u2019s no better summation than a 40-second TikTok video posted in October by a performer named Taylor Rousseau.", "author": {"name": "Fox News 26", "url": "http://www.newspressnow.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/573/normal/Screen_Shot_2016-01-06_at_17.18.30.png?1452100725"}}, {"title": "No, COVID-19 vaccines don\u2019t contain Satan\u2019s microchips (and other scary conspiracy theories aren\u2019t true, either)", "url": "http://ct.moreover.com/?a=43797151892&p=1pl&v=1&x=TK14zhxL-Sk-BLPb_DRxDA", "license": "public", "citation_ids": [94961701, 88564054], "posted_on": "2020-12-15T17:10:00+00:00", "summary": "CHICAGO \u2014 If you want an idea of the conspiracy theories that hang over COVID-19 vaccines, there\u2019s no better summation than a 40-second TikTok video posted in October by a performer named Taylor Rousseau.", "author": {"name": "The Bakersfield Californian", "url": "http://www.bakersfield.com/News", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/396/normal/Screen_Shot_2016-03-31_at_09.40.23.png?1459413641"}}, {"title": "No, COVID-19 vaccines don\u2019t contain Satan\u2019s microchips (and other scary conspiracy theories aren\u2019t true, either)", "url": "http://ct.moreover.com/?a=43797164745&p=1pl&v=1&x=7FSizoAQddQqUIIryXKIMQ", "license": "public", "citation_ids": [94961701, 88564054], "posted_on": "2020-12-15T17:10:00+00:00", "summary": "CHICAGO \u2014 If you want an idea of the conspiracy theories that hang over COVID-19 vaccines, there\u2019s no better summation than a 40-second TikTok video posted in October by a performer named Taylor Rousseau.", "author": {"name": "Herald Mail Media", "url": "http://www.heraldmailmedia.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/587/normal/Screen_Shot_2016-01-06_at_17.38.21.png?1452101946"}}, {"title": "No, COVID-19 vaccines don\u2019t contain Satan\u2019s microchips (and other scary conspiracy theories aren\u2019t true, either)", "url": "http://ct.moreover.com/?a=43797169294&p=1pl&v=1&x=GcB9dQrnfT9nU4lPHXiBRQ", "license": "public", "citation_ids": [94961701, 88564054], "posted_on": "2020-12-15T17:10:00+00:00", "summary": "CHICAGO \u2014 If you want an idea of the conspiracy theories that hang over COVID-19 vaccines, there\u2019s no better summation than a 40-second TikTok video posted in October by a performer named Taylor Rousseau.", "author": {"name": "union-bulletin", "url": "https://www.union-bulletin.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/827/normal/Capture.PNG?1576498803"}}, {"title": "The Lancet: \u0432\u0430\u043a\u0446\u0438\u043d\u0430 Pfizer \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 85% \u0443\u0436\u0435 \u043f\u043e\u0441\u043b\u0435 \u043f\u0435\u0440\u0432\u043e\u0439 \u0434\u043e\u0437\u044b", "url": "http://ct.moreover.com/?a=44277640961&p=1pl&v=1&x=vrOXGhcoGKCCshaFd3e2yA", "license": "public", "citation_ids": [100422247, 88564054], "posted_on": "2021-02-19T00:00:00+00:00", "summary": "\u0412\u0430\u043a\u0446\u0438\u043d\u0430 \u043e\u0442 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u043d\u043e\u0439 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438 \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0441\u0442\u0432\u0430 \u0430\u043c\u0435\u0440\u0438\u043a\u0430\u043d\u0441\u043a\u043e\u0439 \u0444\u0430\u0440\u043c\u043a\u043e\u043c\u043f\u0430\u043d\u0438\u0438 Pfizer \u0438 \u043d\u0435\u043c\u0435\u0446\u043a\u043e\u0439 \u0431\u0438\u043e\u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043a\u043e\u043c\u043f\u0430\u043d\u0438\u0435\u0439 BioNTech \u043e\u043a\u0430\u0437\u0430\u043b\u0430\u0441\u044c \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 85% \u0443\u0436\u0435 \u043f\u043e\u0441\u043b\u0435 \u043f\u0435\u0440\u0432\u043e\u0439 \u0434\u043e\u0437\u044b.", "author": {"name": "Polit", "url": "http://www.polit.ru", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/888/normal/Screen_Shot_2016-01-27_at_13.59.12.png?1453903239"}}, {"title": "\u041f\u0440\u0435\u043c\u044c\u0435\u0440-\u043c\u0438\u043d\u0438\u0441\u0442\u0440 \u042f\u043f\u043e\u043d\u0438\u0438 \u0432\u0430\u043a\u0446\u0438\u043d\u0438\u0440\u043e\u0432\u0430\u043b\u0441\u044f \u043e\u0442 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u0430 \u043f\u0435\u0440\u0435\u0434 \u0432\u0441\u0442\u0440\u0435\u0447\u0435\u0439 \u0441 \u0411\u0430\u0439\u0434\u0435\u043d\u043e\u043c", "url": "http://ct.moreover.com/?a=44469080263&p=1pl&v=1&x=fb4BhIBO4X_R058fx4RTIA", "license": "public", "citation_ids": [88564054], "posted_on": "2021-03-16T00:00:00+00:00", "summary": "\u041f\u0440\u0435\u043c\u044c\u0435\u0440-\u043c\u0438\u043d\u0438\u0441\u0442\u0440 \u042f\u043f\u043e\u043d\u0438\u0438 \u0415\u0441\u0438\u0445\u0438\u0434\u044d \u0421\u0443\u0433\u0430 16 \u043c\u0430\u0440\u0442\u0430 \u043f\u043e\u0441\u0442\u0430\u0432\u0438\u043b \u043f\u0440\u0438\u0432\u0438\u0432\u043a\u0443 \u043e\u0442 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u0430, \u0441\u043e\u043e\u0431\u0449\u0430\u0435\u0442 \u0430\u0433\u0435\u043d\u0442\u0441\u0442\u0432\u043e Kyodo.", "author": {"name": "Polit", "url": "http://www.polit.ru", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/888/normal/Screen_Shot_2016-01-27_at_13.59.12.png?1453903239"}}, {"title": "Pfizer \u043e\u0442\u0447\u0438\u0442\u0430\u043b\u0430\u0441\u044c \u043e 100% \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u0438 \u0441\u0432\u043e\u0435\u0439 \u0432\u0430\u043a\u0446\u0438\u043d\u044b \u043e\u0442 \u043a\u043e\u0432\u0438\u0434\u0430 \u0441\u0440\u0435\u0434\u0438 \u043f\u043e\u0434\u0440\u043e\u0441\u0442\u043a\u043e\u0432 12\u201315 \u043b\u0435\u0442", "url": "http://ct.moreover.com/?a=44585951690&p=1pl&v=1&x=Q6iljhXMscrDtdrceWMj8g", "license": "public", "citation_ids": [88564054], "posted_on": "2021-03-31T00:00:00+00:00", "summary": "\u0412\u0430\u043a\u0446\u0438\u043d\u0430 \u043e\u0442 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u043d\u043e\u0439 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438 \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0441\u0442\u0432\u0430 \u0430\u043c\u0435\u0440\u0438\u043a\u0430\u043d\u0441\u043a\u043e\u0439 \u0444\u0430\u0440\u043c\u043a\u043e\u043c\u043f\u0430\u043d\u0438\u0438 Pfizer \u0438 \u043d\u0435\u043c\u0435\u0446\u043a\u043e\u0439 \u0431\u0438\u043e\u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043a\u043e\u043c\u043f\u0430\u043d\u0438\u0435\u0439 BioNTech \u043e\u043a\u0430\u0437\u0430\u043b\u0430\u0441\u044c \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 100% \u0441\u0440\u0435\u0434\u0438 \u043f\u043e\u0434\u0440\u043e\u0441\u0442\u043a\u043e\u0432 12\u201315 \u043b\u0435\u0442, \u0433\u043e\u0432\u043e\u0440\u0438\u0442\u0441\u044f \u043d\u0430 \u0441\u0430\u0439\u0442\u0435 Pfizer.", "author": {"name": "Polit", "url": "http://www.polit.ru", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/888/normal/Screen_Shot_2016-01-27_at_13.59.12.png?1453903239"}}], "blogs": [{"title": "More Pfizer/BioNTech Data On Their Actual Vaccine Candidate", "url": "https://blogs.sciencemag.org/pipeline/archives/2020/08/20/more-pfizer-biontech-data-on-their-actual-vaccine-candidate", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T15:30:24+00:00", "summary": "When we last heard from the Pfizer/BioNTech vaccine program, they had picked a different candidate than the one that they had already published on (BNT162b1). Today they&#8217;ve released more data about the actual candidate,\u00a0BNT162b2. And it seems pretty", "author": {"name": "In the Pipeline", "url": "http://blogs.sciencemag.org/pipeline", "description": "Derek&rsquo;s excellent commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine."}}, {"title": "Coronavirus: Pfizer\u2019s second vaccine has fewer side effects", "url": "https://whatsnew2day.com/coronavirus-pfizers-second-vaccine-has-fewer-side-effects/", "license": "public", "citation_ids": [88564054], "posted_on": "2020-08-20T21:07:56+00:00", "summary": "Pfizer&#8217;s second experimental coronavirus vaccine left HALF so many people with side effects compared to the first in a promising sign for a safe shot\n\nBoth vaccines use part of the genetic code of the coronavirus.  but B1 encodes part of the protein", "author": {"name": "Whats New", "url": "https://whatsnew2day.com/"}}, {"title": "Phase 3 Results in Sight for Some, While One Vaccine is Put on Hold: Covid-19 Vaccine Race, Month 9", "url": "https://absolutelymaybe.plos.org/2020/09/11/phase-3-results-in-sight-for-some-while-one-vaccine-is-put-on-hold-covid-19-vaccine-race-month-9/", "license": "public", "citation_ids": [82786927, 89710114, 2898064, 85834073, 88564054, 89687303, 89390961, 89462032, 82507792], "posted_on": "2020-09-11T14:20:04+00:00", "summary": "We\u2019re now into the ninth month since sequencing of the genome of SARS-Cov-2, the virus that causes Covid-19. And this is the fourth of my month-by-month posts about the vaccine race.&nbsp;This month, there&#8217;s a lot of good news: We are on", "author": {"name": "Absolutely Maybe", "url": "https://absolutelymaybe.plos.org/"}}, {"title": "H\u00e1nyat kell m\u00e9g aludni a vakcin\u00e1ig?", "url": "https://qubit.hu/2020/09/15/hanyat-kell-meg-aludni-a-vakcinaig", "license": "public", "citation_ids": [85794306, 86139797, 86123198, 85041504, 88564054, 82550101, 86139672, 88937640, 88202546, 89071069, 89462032, 87852864], "posted_on": "2020-09-15T05:42:18+00:00", "summary": "Miut\u00e1n az AstraZeneca gy\u00f3gyszergy\u00e1rt\u00f3 szeptember 8-\u00e1n bejelentette, hogy le\u00e1ll\u00edtotta az Oxfordi Egyetemmel partners\u00e9gben fejlesztett, egyik leg\u00edg\u00e9retesebb COVID-19-vakcina harmadik f\u00e1zisban tart\u00f3, vagyis t\u00f6bb ezer ember r\u00e9szv\u00e9tel\u00e9vel zajl\u00f3 tesztel\u00e9s\u00e9t, so", "author": {"name": "Qubit", "url": "https://qubit.hu/"}}, {"title": "#MSCOVID19 Vaccine Shows Efficacy inn Phase III", "url": "https://multiple-sclerosis-research.org/2020/11/mscovid19-vaccine-shows-efficacy-inn-phase-iii/?utm_source=rss&utm_medium=rss&utm_campaign=mscovid19-vaccine-shows-efficacy-inn-phase-iii", "license": "public", "citation_ids": [88564054, 94385734], "posted_on": "2020-11-09T16:49:10+00:00", "summary": "The race to produce the first licenced COVID-19 has been wone by&#8230;.the Russians. OK it was abit of a fiddle as they approved without doing the necessary tests. So we will ignore this. However good news for humanity and MS.\n\n\n\nIf you have MS and or on", "author": {"name": "Multiple Sclerosis Research", "url": "http://multiple-sclerosis-research.blogspot.com/", "description": "A blog for people with MS and their families, by Barts and The London School of Medicine and Dentistry."}}, {"title": "Peter Doshi: Pfizer and Moderna\u2019s \u201c95% effective\u201d vaccines\u2014let\u2019s be cautious and first see the full data", "url": "https://blogs.bmj.com/bmj/2020/11/26/peter-doshi-pfizer-and-modernas-95-effective-vaccines-lets-be-cautious-and-first-see-the-full-data/", "license": "public", "citation_ids": [92838069, 92845144, 94797428, 88778764, 433003, 94968613, 1856127, 88564054, 91430619, 85794306, 92401921, 94968613, 1856127, 88564054, 91430619, 85794306, 92401921], "posted_on": "2020-11-26T14:24:58+00:00", "summary": "Only full transparency and rigorous scrutiny of the data will allow for informed decision making, argues Peter Doshi\nIn the United States, all eyes are on Pfizer and Moderna. The topline efficacy results from their experimental covid-19 vaccine trials are", "author": {"name": "Latest BMJ blogs", "url": "http://blogs.bmj.com/bmj", "description": "Just another blogs.bmj.com weblog"}}, {"title": "British Medical Journal Editor Calls Into Question Pfizer & Moderna\u2019s \u201c95% Effective\u201d COVID Vaccines", "url": "https://jonsnewplace.wordpress.com/2020/12/15/british-medical-journal-editor-calls-into-question-pfizer-modernas-95-effective-covid-vaccines/", "license": "public", "citation_ids": [92838069, 92845144, 94797428, 88778764, 433003, 94968613, 1856127, 88564054, 91430619, 85794306, 92401921, 4199548, 94219858], "posted_on": "2020-12-15T22:48:08+00:00", "summary": "Collective Evolution December 8, 2020 Arjun Walia The Facts:Dr. Peter Doshi, an associate editor at the British Medical Journal published a piece in the Journal issuing a word of caution about the supposed &#8220;95% Effective&#8221; COVID vaccines from Pf", "author": {"name": "Wake Up To The Truth", "url": "https://jonsnewplace.wordpress.com/"}}], "video": [{"title": "Potential Covid 19 Vaccines", "url": "https://www.youtube.com/watch?v=bw0sJ7p5lWE", "image": "https://i.ytimg.com/vi/bw0sJ7p5lWE/hqdefault.jpg", "license": "public", "citation_ids": [85794306, 86791482, 89352278, 88564054, 85794306, 89352278], "posted_on": "2020-11-19T09:18:18+00:00", "summary": "References:\nhttps://unsplash.com/photos/EAgGqOiDDMg\nhttps://www.nejm.org/doi/full/10.1056/nejmoa2022483\nhttps://www.nature.com/articles/s41586-020-2608-y\nhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa2026920\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC744430", "embed": {"type": "youtube", "youtube_id": "bw0sJ7p5lWE"}, "author": {"name": "Aaditya D Singh", "id_on_source": "UCUxtEJJ1DWMA_6qQJ7xHH4Q"}}, {"title": "The Truth About COVID Vaccines and Emergency Use Authorizations", "url": "https://www.youtube.com/watch?v=IVlULRMvcjI", "image": "https://i.ytimg.com/vi/IVlULRMvcjI/hqdefault.jpg", "license": "public", "citation_ids": [88564054, 95220371, 85794306, 92838069, 85794306], "posted_on": "2020-12-04T22:09:52+00:00", "summary": "The news of several promising COVID-19 vaccines over the past few weeks has been very exciting, but so far, none have received emergency authorization for general use in the US. We'll talk about what that means, and also, why these vaccines are unlike any", "embed": {"type": "youtube", "youtube_id": "IVlULRMvcjI"}, "author": {"name": "SciShow", "id_on_source": "UCZYTClx2T1of7BRZ86-8fow"}}], "wikipedia": [{"title": "Fosun Pharmaceutical", "url": "http://en.wikipedia.org/?diff=prev&oldid=989807651#altmetric_citation_dabe5b25-7ccc-44b4-b95a-6d90265445f0", "license": "public", "citation_ids": [88564054, 88564054], "posted_on": "2020-11-21T03:56:06+00:00", "summary": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd., known as Fosun Pharmaceutical or just Fosun Pharma is a Chinese listed pharmaceutical company.", "page_url": "http://en.wikipedia.org/?curid=58045046", "wiki_lang": "en", "author": {"name": "Albertaont", "url": "http://en.wikipedia.org/wiki/User:Albertaont"}}, {"title": "BNT162b2", "url": "http://sv.wikipedia.org/?diff=prev&oldid=48549312#altmetric_citation_70b4f4d6-be9f-4da0-a164-053f0d06b0c3", "license": "public", "citation_ids": [88564054, 88564054, 88564054], "posted_on": "2020-12-10T16:36:48+00:00", "summary": "BNT162b2, ocks\u00e5 Tozinameran efter dess aktiva ingrediens, \u00e4r ett Covid-19-vaccin som utvecklats av det tyska l\u00e4kemedelbolaget BioNTech tillsammans med det amerikanska l\u00e4kemedelsbolaget Pfizer.", "page_url": "http://sv.wikipedia.org/?curid=8510382", "wiki_lang": "sv", "author": {"name": "Boberger", "url": "http://sv.wikipedia.org/wiki/User:Boberger"}}]}, "score": 1155.704, "images": {"small": "https://badges.altmetric.com/?size=64&score=1156&types=mbvttttw", "medium": "https://badges.altmetric.com/?size=100&score=1156&types=mbvttttw", "large": "https://badges.altmetric.com/?size=180&score=1156&types=mbvttttw"}}